header logo image


Page 908«..1020..907908909910..920930..»

Inattentional blindness – Wikipedia

January 15th, 2019 8:47 am

Inattentional blindness, also known as perceptual blindness, is a psychological lack of attention that is not associated with any vision defects or deficits. It may be further defined as the event in which an individual fails to perceive an unexpected stimulus that is in plain sight. When it simply becomes impossible for one to attend to all the stimuli in a given situation, a temporary blindness effect can take place as a result; that is, individuals fail to see objects or stimuli that are unexpected and quite often salient.[1] The term was coined by Arien Mack and Irvin Rock in 1992 and was used as the title of their book of the same name, published by MIT press in 1998,[2] in which they describe the discovery of the phenomenon and include a collection of procedures used in describing it.[3] A famous study that demonstrated inattentional blindness asked participants whether or not they noticed a gorilla walking through the scene of a visual task they had been given.[1]

Research on inattentional blindness suggests that the phenomenon can occur in any individual, independent of cognitive deficits. However, recent evidence shows that patients with ADHD performed better attentionally when engaging in inattentional blindness tasks than control patients did,[4] suggesting that some mental deficits may decrease the effects of this phenomenon. Recent studies have also looked at age differences and inattentional blindness scores, and results show that the effect increases as humans age.[5][6][7] There is mixed evidence that consequential unexpected objects are noticed more: Some studies suggest that we can detect threatening unexpected stimuli more easily than nonthreatening ones,[8][9] but other studies suggest that this is not the case.[10][11][12] There is some evidence that objects associated with reward are noticed more.[12]

Numerous experiments[13] and art work [14][15][16][17] has demonstrated that inattentional blindness also has an effect on people's perception.

The following criteria are required to classify an event as an inattentional blindness episode: 1) the observer must fail to notice a visual object or event, 2) the object or event must be fully visible, 3) observers must be able to readily identify the object if they are consciously perceiving it,[3] and 4) the event must be unexpected and the failure to see the object or event must be due to the engagement of attention on other aspects of the visual scene and not due to aspects of the visual stimulus itself.[3] Individuals who experience inattentional blindness are usually unaware of this effect, which can play a subsequent role on behavior.

Inattentional blindness is related to but distinct from other failures of visual awareness such as change blindness, repetition blindness, visual masking, and attentional blink. The key aspect of inattentional blindess which makes it distinct from other failures in awareness rests on the fact that the undetected stimulus is unexpected.[18] It is the unexpected nature of said stimulus that differentiates inattentional blindness from failures of awareness such as attentional failures like the aforementioned attentional blink. It is critical to acknowledge that occurrences of inattentional blindness are attributed to the failure to consciously attend to an item in the visual field as opposed the absence of cognitive processing.

Findings such as inattentional blindness the failure to notice a fully visible but unexpected object because attention was engaged on another task, event, or object has changed views on how the brain stores and integrates visual information, and has led to further questioning and investigation of the brain and importantly of cognitive processes.

Cognitive capture or, cognitive tunneling, is an inattentional blindness phenomenon in which the observer is too focused on instrumentation, task at hand, internal thought, etc. and not on the present environment. For example, while driving, a driver focused on the speedometer and not on the road is suffering from cognitive capture.[a]

One of the most foremost conflicts among researchers of inattentional blindness surrounds the processing of unattended stimuli. More specifically, there is disagreement in the literature about exactly how much processing of a visual scene is completed before selection dictates which stimuli will be consciously perceived, and which will not be (i.e. inattentional blindness). There exists two basic schools of thought on the issue those who believe selection occurs early in the perceptual process, and those who believe it occurs only after significant processing.[19] Early selection theorists propose that perception of stimuli is a limited process requiring selection to proceed. This suggests that the decision to attend to specific stimuli occurs early in processing, soon after the rudimentary study of physical features; only those selected stimuli are then fully processed. On the other hand, proponents of late selection theories argue that perception is an unlimited operation, and all stimuli in a visual scene are processed simultaneously. In this case, selection of relevant information is done after full processing of all stimuli.[20]

While early research on the topic was heavily focused on early selection, research since the late 1970s has been shifted mainly to the late selection theories. This change resulted primarily from a shift in paradigms used to study inattentional blindness which revealed new aspects of the phenomenon.[21] Today, late selection theories are generally accepted, and continue to be the focus of the majority of research concerning inattentional blindness.

A significant body of research has been gathered in support of late selection in the perception of visual stimuli.

One of the popular ways of investigating late selection is to assess the priming properties (i.e. influencing subsequent acts[22]) of unattended stimuli. Often used to demonstrate such effects is the stem completion task. While there exist a few variations, these studies generally consist of showing participants the first few letters of words, and asking them to complete the string of letters to form an English word.[22] It has been demonstrated that observers are significantly more likely to complete word fragments with the unattended stimuli presented in a trial than with another similar word.[2] This effect holds when stimuli are not words, but instead objects. When photos of objects are shown too quickly for participants to identify, subsequent presentation of those items lead to significantly faster identification in comparison to novel objects.[22]

A notable study by Mack and Rock has also revealed that showing a word stimulus differing from the participant's name by one letter did not generally call conscious attention. By simply changing a character, transforming the presented word into the observer's first name, the now highly meaningful stimulus is significantly more likely to be attended to. This suggests that the stimuli are being extensively processed, at least enough to analyze their meaning. These results point to the fact that attentional selection may be determined late in processing.[2]

The evidence outlined above suggests that even when stimuli are not processed to the level of conscious attention, they are nonetheless perceptually and cognitively processed, and can indeed exert effects on subsequent behavior.[23]

While the evidence supporting late selection hypotheses is significant and has been consistently reproduced, there also exists a body of research suggesting that unattended stimuli in fact may not receive significant processing.

For example, in an functional magnetic resonance imaging (fMRI) study by Rees and colleagues, brain activity was recorded while participants completed a perceptual task. Here they examined the neural processing of meaningful (words) and meaningless (consonant string) stimuli both when attended to, and when these same items were unattended. While no difference in activation patterns were found between the groups when the stimuli were unattended, differences in neural processing were observed for meaningful versus meaningless stimuli to which participants overtly attended. This pattern of results suggests that ignored stimuli are not processed to the level of meaning, i.e. less extensively than attended stimuli.[24] Participants do not seem to be detecting meaning in stimuli to which they are not consciously attending.

This particular hypothesis bridges the gap between the early and late selection theories. Authors integrate the viewpoint of early selection stating that perception is a limited process (i.e. cognitive resources are limited), and that of the late selection theories assuming perception as an automatic process.[20] This view proposes that the level of processing which occurs for any one stimulus is dependent on the current perceptual load. That is, if the current task is attentionally demanding and its processing exhausts all the available resources, little remains available to process other non-target stimuli in the visual field. Alternatively, if processing requires a small amount of attentional resources, perceptual load is low and attention is inescapably directed to the non-target stimuli.[19]

The effects of perceptual load on the occurrence of inattentional blindness is demonstrated in a study by Fougnie and Marois. Here, participants were asked to complete a memory task involving either the simple maintenance of verbal stimuli, or the rearrangement of this material, a more cognitively demanding exercise. While subjects were completing the assigned task, an unexpected visual stimulus was presented. Results revealed that unexpected stimuli were more likely to be missed during manipulation of information than in the more simple rehearsal task.[25]

In a similar type of study, fMRI recordings were done while subjects took part in either low-demand or high-demand subtraction tasks. While performing these exercises, novel visual distractors were presented. When task demands were low and used a smaller portion of the finite resources, distractors captured attention and sparked visual analysis as shown by brain activation in the primary visual cortex. These results, however, did not hold when perceptual load was high; in this condition, distractors were significantly less often attended to and processed.[19]

Thus, higher perceptual load, and therefore more significant use of attentional resources, appears to increase the likelihood of inattentional blindness episodes.

The theory of inattentional amnesia provides an alternative in the explanation of inattentional blindness in suggesting that the phenomenon does not stem from failures in capture of attention or in actual perception of stimuli, but instead from a failure in memory. The unnoticed stimuli in a visual scene are attended to and consciously perceived, but are rapidly forgotten rendering them impossible to report.[26] In essence, inattentional amnesia refers to the failure in creating a lasting explicit memory: by the time a subject is asked to recall seeing an item, their memory for the stimulus has vanished.[27]

While it is difficult to tease apart a failure in perception from one in memory, some research has attempted to shed light on the issue. In a now-classic study of inattentional blindness, a woman carrying an umbrella through a scene goes unnoticed. Despite stopping the video while she is walking through and immediately asking participants to identify which of two people they have seen leaving as little delay as possible between presentation and report observers very often fail to correctly identify the woman with the umbrella. No differences in performance were identified whether the video was stopped immediately after the unexpected event or moments later. These findings would seem to oppose the idea of inattentional amnesia, however advocates of the theory could always contend that the memory test simply came too late and that the memory had already been lost.[28]

The very phenomenon of inattentional blindness is defined by a lack of expectation for the unattended stimulus. Some researchers believe that it is not inattention that produces blindness, but in fact the aforementioned lack of expectation for the stimuli.[23] Proponents of this theory often state that classic methods for testing inattentional blindness are not manipulating attention per se, but instead the expectation for the presentation of a visual item.[29]

Studies investigating the effect of expectation on episodes of inattentional blindness have shown that once observers are made aware of the importance of the stimuli to be presented, for example stating that one will later be tested on it, the phenomenon essentially disappears.[2] While admitting to possible ambiguities in methodology, Mack, one of the foremost researchers in the field, holds strongly that inattentional blindness stems predominantly from a failure of attentional capture. She points out that if expectation does not mediate instances of very closely linked phenomena such as attentional blink and change blindness (whereby participants have difficulty identifying the changing object even when they are explicitly told to look for it), it is unlikely that inattentional blindness can be explained solely by a lack of expectation for stimulus presentation.[23]

The perceptual cycle framework has been used as another theoretical basis for inattentional blindness. The perceptual cycle framework describes attention capture and awareness capture as occurring at two different stages of processing. Attention capture occurs when there is a shift in attention due to the salience of a stimuli, and awareness capture refers to the conscious acknowledgement of stimuli. Attentional sets are important because it is composed of characteristics of stimuli an individual is processing. Inattentional blindness occurs when there is an interaction between an individual's attentional set and the salience of the unexpected stimulus. Recognizing the unexpected stimulus can occur when the characteristics of the unexpected stimulus resembles the characteristics of the perceived stimuli. The attentional set theory of inattentional blindness has implications for false memories and eyewitness testimony. The perceptual cycle framework offers four major implications about inattentional blindness 1) environmental cues aid in the detection of stimuli by providing orienting cues but is not enough to produce awareness, 2) perception requires effortful sustained attention, interpretation, and reinterpretation, 3) implicit memory may precede conscious perception, and 4) visual stimuli that is not expected, explored, or interpreted may not be perceived.[30]

Other bases for attentional blindness include top down and bottom up processing.

To test for inattentional blindness, researchers ask participants to complete a primary task while an unexpected stimulus is presented. Afterwards, researchers ask participants if they saw anything unusual during the primary task. Arien Mack and Irvin Rock describe a series of experiments that demonstrated inattentional blindness in their 1998 book, Inattentional Blindness.

The best-known study demonstrating inattentional blindness is the Invisible Gorilla Test, conducted by Daniel Simons of the University of Illinois at Urbana-Champaign and Christopher Chabris of Harvard University. This study, a revised version of earlier studies conducted by Ulric Neisser, Neisser and Becklen in 1975, asked subjects to watch a short video of two groups of people (wearing black and white T-shirts) passing a basketball around. The subjects are told either to count the passes made by one of the teams or to keep count of bounce passes vs. aerial passes. In different versions of the video a person walks through the scene carrying an umbrella (as discussed above) or wearing a full gorilla suit. After watching the video, the subjects are asked whether they noticed anything out of the ordinary taking place. In most groups, 50% of the subjects did not report seeing the gorilla (or the person with the umbrella). Failure to perceive the anomalies is attributed to failure to attend to it while engaged in the difficult task of counting passes of the ball. These results indicate that the relationship between what is in one's visual field and perception is based much more on attention than was previously thought.[31]

Out 228 participants of the tests, only 194 those who did count the passes correctly were used for statistical purposes further. The percentage was even as low as 8% in one of the 16 tests performed.[32][33]

The basic Simons and Chabris study was reused on British television as a public safety advert designed to point out the potential dangers to cyclists caused by inattentional blindness in motorists. In the advert the gorilla is replaced by a moon-walking bear.[34]

In 1995, Officer Kenny Conley was chasing a shooting suspect. An undercover officer was in the same vicinity and was mistakenly taken down by other officers while Conley ran by and failed to notice. A jury later convicted Officer Conley of perjury and obstruction of justice, believing he had seen the fight and lied about it to protect fellow officers, yet he stood by his word that he had, in fact, not seen it.[35]

Christopher Chabris, Adam Weinberger, Matthew Fontaine and Daniel J. Simons took it upon themselves to see if this scenario was possible. They designed an experiment in which participants were asked to run about 30 feet behind an experimenter, and count how many times he touched his head. A fight was staged to appear about 8 meters off the path, and was visible for approximately 15 seconds. The procedure in its entirety lasted about 2 minutes and 45 seconds, and participants were then asked to report the number of times they had seen the experimenter touch his head with either hand (medium load), both hands (high load), or were not instructed to count at all (low load). After the run, participants were asked 3 questions: 1) If they had noticed the fight; 2) if they had noticed a juggler, and 3) if they had noticed someone dribbling a basketball. Questions 2) and 3) were control questions, and no one falsely reported these as true.

Participants were significantly more likely to notice the fight when the experiment was done during the day as opposed to in the dark. Additionally, sightings of the fight were most likely to be reported in the low load condition (72%) than in either the medium load (56%), or high load conditions (42%).[36] These results exemplify a real world occurrence of inattentional blindness, and provide evidence that officer Conley could indeed have missed the fight because his attention was focused elsewhere. Moreover, these results add to the body of knowledge suggesting that as perceptual load increases, less resources remain to process items not explicitly focused on, and in turn episodes of inattentional blindness become more frequent.

Another experiment was conducted by Steven Most, along with Daniel Simons, Christopher Chabris and Brian Scholl. Instead of a basketball game, they used stimuli presented by computer displays. In this experiment objects moved randomly on a computer screen. Participants were instructed to attend to the black objects and ignore the white, or vice versa. After several trials, a red cross unexpectedly appeared and traveled across the display, remaining on the computer screen for five seconds. The results of the experiment showed that even though the cross was distinctive from the black and white objects both in color and shape, about a third of participants missed it. They had found that people may be attentionally tuned to certain perceptual dimensions, such as brightness or shape. Inattentional blindness is most likely to occur if the unexpected stimuli presented resembles the environment.[37]

One interesting experiment displayed how cell phones contributed to inattentional blindness in basic tasks such as walking. The stimulus for this experiment was a brightly colored clown on a unicycle. The individuals participating in this experiment were divided into four sections. They were either talking on the phone, listening to an mp3 player, walking by themselves or walking in pairs. The study showed that individuals engaged in cell phone conversations were least likely to notice the clown. This experiment was designed by Ira E. Hyman, S. Matthew Boss, Breanne M. Wise, Kira E. Mckenzie and Jenna M. Caggiano at Western Washington University.[38]

Daniel Memmert conducted an experiment which suggests that an individual can look directly at an object and still not perceive it. This experiment was based on the invisible gorilla experiment. The participants were children with an average age of 7.7 years. Participants watched a short video of a six-player basketball game (three with white shirts, three with black shirts). The participants were instructed to watch only the players wearing black shirts and to count the times the team passed the ball. During the video a person in a gorilla suit walks through the scene. The film was projected onto a large screen (3.2 m X 2.4 m) and the participants sat in a chair 6 meters from the screen. Participants' eye movement and fixations were recorded during the video, and afterward the participants answered a series of questions.

Only 40% of the participants reported seeing the gorilla. There was no significant difference in accuracy of the counting between the two groups. Analyzing the eye movement and fixation data showed no significant difference in time spent looking at the players (black or white) between the two groups. However, the 60% of participants who did not report seeing the gorilla spent an average of 25 frames (about one second) fixated on the gorilla, despite not perceiving it.[39]

A more common example of blindness despite fixation is illustrated in the game of Three-card Monte.

Another experiment conducted by Daniel Memmert tested the effects of different levels of expertise can have on inattentional blindness. The participants in this experiment included six different groups: Adult basketball experts with an average of twelve years of experience, junior basketball experts with an average of five years, children who had practiced the game for an average of two years, and novice counterparts for each age group. In this experiment the participants watched the invisible gorilla experiment video. The participants were instructed to watch only the players wearing white and to count the times the team passed the ball.

The results showed that experts did not count the passes more accurately than novices but did show that adult subjects were more accurate than the junior and child subjects. A much higher percentage of experts noticed the gorilla compared with novices and even the practiced children. 62% of the adult experts and 60% of the junior experts noticed the gorilla, suggesting that the difference between five and twelve years of experience has minimal effect on inattentional blindness. However, only 38% of the adult, 35% of the junior, and none of the child novices noticed the gorilla. Only 18% of the children with two years of practice noticed. This suggests that both age and experience can have a significant effect on inattentional blindness.[39]

Arien Mack and Irvin Rock's concluded in 1998 that no conscious perception can occur without attention.[2] Evidence through research on inattentional blindness contemplates that it may be possible that inattentional blindness reflects a problem with memory rather than with perception.[2] It is argued that at least some instances of inattentional blindness are better characterized as memory failures than perceptual failures. The extent to which unattended stimuli fail to engage perceptual processing is an empirical question that the combination of inattentional blindness and other various measures of processing can be used to address.[3]

The theory behind inattentional blindness research suggests that we consciously experience only those objects and events to which we directly attend.[2] That means that the vast majority of information in our field of vision goes unnoticed. Thus if we miss the target stimulus in an experiment, but are later told about the existence of the stimulus, this sufficient awareness allows participants to report and recall the stimulus now that attention has been allocated to it.[3] Mack and Rock, and their colleagues discovered a striking array of visual events to which people are inattentionally blind.[2] However the debate arises whether this inattentional blindness was due to memory or perceptual processing limitations.

Mack and Rock note that explanations for inattentional blindness can reflect a basic failure of perceptual processes to be engaged by unattended stimuli. Or that it may reflect a failure of memorial processes to encode information about unattended stimuli. It is important to note that the memory failure does not have to do with forgetting something that has been encoded by losing access to the memory of the stimulus from time of presentation to time of retrieval, rather that the failure is attributed to information not being encoded when the stimulus was present.[2] It seems that inattentional blindness can be explained by both memory and perceptual failures because in experimental research participants may fail to report what was on display due to failures in encoded information (memory) or a failure in perceptually processed information (perception).[2]

There are similarities in the types of unconscious processing apparent in inattentional blindness and in neuropsychological syndromes such as visual neglect and extinction. The analogy between these phenomenon's seems to generate more questions as well as answers. These answers are fundamental for our understanding of the relationship between attention, stimulus coding and behavior.

Research has shown that some aspects of the syndrome of unilateral visual neglect appear to be similar to normal subjects in a state of inattentional blindness. In neglect, patients with lesions to the parietal cortex fail to respond to and report stimuli presented on the side of space contralateral to damage.[23][40] That is, they appear to be functionally blind to a range of stimuli. Since such lesions do not result in any sensory deficits, shortcomings have been explained in terms of a lack of attentional processing, for which the parietal cortex plays a large role.[41] These phenomena draw strong parallels to one another, as in both cases stimuli are perceptible but unreported when unattended.

In the phenomenon of extinction, patients can report the presence of a single stimulus presented on the affected side, but then fail to detect it when a second stimulus is presented simultaneously on the "good" (ipsilateral) side.[42] Here the stimulus on the affected side seems to lose under conditions of attentional competition from stimuli in the ipsilesional field.[42] The consequence of this competition is that the extinguished items may not be detected.

Similar to studies of inattentional blindness, there is evidence of processing taking place in the neglected field. For example, there can be semantic priming from a stimulus presented in the neglected field, which affects responses to stimuli subsequently presented on the unimpaired side.[43] Apparently in both neglect and inattentional blindness, there is some level processing of stimuli even when they are unattended.[43] However one major difference between neuropsychological symptoms such as neglect and extinction, and inattentional blindness concerns the role of expectation.[43] In inattentional blindness, subjects do not expect the unreported stimulus. In contrast, in neglect and extinction, patients may expect a stimulus to be presented on the affected side but still fail to report it when another it may be that expectation affects reportability but not the implicit processing of stimuli.[43]

Further explanations of the phenomenon of inattentional blindness include inattentional amnesia, inattentional agnosia and change blindness.

An explanation for this phenomenon is that observers see the critical object in their visual field but fail to process it extensively enough to retain it. Individuals experience inattentional agnosia after having seen the target stimuli but not consciously being able to identify what the stimuli is. It is possible that observers are not even able to identify that the stimuli they are seeing are coherent objects.[44] Thus observers perceive some representation of the stimuli but are actually unaware of what that stimulus is. It is because the stimulus is not encoded as a specific thing, that it later is not remembered. Individuals fail to report what the stimuli is after it has been removed. However, despite a lack in ability to fully process the stimuli, experiments have shown a priming effect of the critical stimuli. This priming effect indicates that the stimuli must have been processed to some degree, this occurs even if observers are unable to report what the stimuli is.[45]

Inattentional blindness is the failure to see a stimulus, such as an object that is present in a visual field. However, change blindness is the failure to notice something different about a visual display. Change blindness is a directly related to memory, individuals who experience the effects of change blindness fail to notice something different about a visual display from one moment to the next.[18] In experiments that test for this phenomenon participants are shown an image that is then followed by another duplicate image that has had a single change made to it. Participants are asked to compare and contrast the two images and identify what the change is. In inattentional blindness experiments, participants fail to identify some stimulus in a single display, a phenomenon that doesn't rely on memory the way change blindness does.[18] Inattentional blindness refers to an inability to identify an object all together whereas change blindness is a failure to compare a new image or display to one that was previously stored in memory.[18]

In 2006, Daniel Memmert conducted a series of studies in which he tested the how age and expertise of participants affect inattentional blindness. Using the gorilla video, he tested 6 different groups of participants. There were 2 groups of children (average age=7) half with no experience in basketball, and the other half with 2 years experience; 2 groups of juniors (average age=13) half with no experience in basketball, and the other half with 5 years of experience; and 2 groups of adults (average age = 24) half with no experience in basketball, the other half with over 12 years of experience. He then instructed all the groups to keep track of how many passes the people on the black team made.

Overall, the children with or without any basketball experience failed to perceive the gorilla more than the juniors or the adults. There were no significant difference between the inexperienced junior and adult groups, or between the experienced junior and adult groups.[39] This pattern of results suggests that until the approximate age of 13, presumably because certain aspects of cognition are still under development, inattentional blindness occurrences are more frequent, but become consistent throughout the remainder of the life span.

Additionally, the juniors with basketball experience noticed the gorilla significantly more than the juniors with no basketball experience; and the group of experienced adults noticed the gorilla significantly more than the non-experienced adults. This suggests that if one has had much experience with the stimuli in a visual field, they are more likely to consciously perceive the unexpected object.

In 2011, Elizabeth Graham and Deborah Burke conducted a study that assessed whether or not older adults are more susceptible to inattentional blindness than younger adults by having 51 younger-aged participants (17 to 22 years) and 61 older-aged participants (61 to 81 years) watch the classic gorilla video. Overall, they found that younger-aged participants were more likely to notice the unexpected gorilla than older-aged participants.[5]

In a 2015 study,[6] Cary Stothart, Walter Boot, and Daniel Simons attempted to replicate and extend the findings from both Graham and Burke's 2011 study and Steven Most and colleague's 2000 study[46] on Amazon Mechanical Turk using a sample of 515 participants that varied in age. In this study, participants were tasked with counting the number of times a number of white moving objects crossed the vertical midpoint of a display while ignoring a number of black moving objects. The unexpected object in this case was a gray cross that moved horizontally across the display at various distances from the vertical midpoint (this was manipulated between participants). Overall, they found that inattentional blindness susceptibility increases with age, which replicates the finding from Graham and Burke. In fact, they found that every 10 years of age was associated with a 1.3 fold increase in the probability of displaying inattentional blindness. They also found that the probability of inattentional blindness increases as the distance between the observer's focus of attention and the unexpected object increases, which replicates the finding from Most and colleagues. However, they also found that the relationship that age has with inattentional blindness does not change as a function of the unexpected object's distance from the focus of attention, suggesting that useful field of view does not mediate the relationship between age and inattentional blindness.

A series of studies conducted to test how similarity can influence the perception of a present stimulus. In the study, they asked participants to fixate on a central point on a computer screen and count how many times either white or black letters bounced off the edges of the screen. The first 2 trials did not contain an unexpected event, but the third trial was the critical trial in which a cross that had the same dimensions as the letters and varied in colour (white/light gray/dark gray/black) moved from the right side of the screen to the left side and passed through the central point. The results revealed the following: during the critical event, the more similar the colour of the cross was to the colour of the attended letters, the more likely the participants were to perceive it, and the less similar the colour of the cross was to the attended colour decreased the likelihood of the cross being noticed. For the participants attending to the black letters, 94% perceived the black cross; 44% perceived the dark gray cross; 12% perceived the light gray cross, and only 6% perceived the white cross. Similarly, if the participant was attending to the white letters, they were more likely to notice the cross it was white (94%) than if it was light gray (75%), dark gray (56%), or black (0%).[31] This study demonstrates that the more similar an unexpected object is to the attended object, the more likely it is to be perceived, thus reducing the chance of inattentional blindness.

A large experiment conducted on 794 participants by Schofield, Creswell and Denson[47] found evidence that completing a brief mindfulness exercise reduced rates on inattentional blindness, but did not improve the depth of encoding of the unexpected distractor. Participants in this experiment engaged in a guided-audio task of mindfully eating a raisin, a well-known task introduced by Kabat-Zinn in his mindfulness-based stress reduction program, or listened to factual descriptions about raisins. The audio recordings used to manipulate mindful states in this experiment are freely available online.[48] Participants who completed the raisin-eating task had 41% greater odds of noticing an unexpected red cross that floated across the screen. Participants were then asked to select the shape that had unexpectedly appeared (i.e., the red cross) out of a line-up of 3 red and 3 green shapes. Those in the mindfulness condition were no better than those in the control condition at selecting the red cross out of the line-up. This was true regardless of whether or not detection of the unexpected distractor was statistically controlled. This experiment demonstrated that not only does mindfulness affect inattentional blindness, but that detailed encoding of the unexpected distractor can be dissociated from the detection of the unexpected distractor.

The research that has been done on inattentional blindness suggests that there are four possible causes for this phenomenon. These include: conspicuity, mental workload, expectations, and capacity.[22]

Conspicuity refers to an object's ability to catch a person's attention. When something is conspicuous it is easily visible. There are two factors which determine conspicuity: sensory conspicuity and cognitive conspicuity. Sensory conspicuity factors are the physical properties an object has. If an item has bright colors, flashing lights, high contrast with environment, or other attention-grabbing physical properties it can attract a person's attention much easier. For example, people tend to notice objects that are bright colors or crazy patterns before they notice other objects. Cognitive conspicuity factors pertain to objects that are familiar to someone. People tend to notice objects faster if they have some meaning to their lives. For example, when a person hears his/her name, their attention is drawn to the person who said it. The cocktail party effect describes the cognitive conspicuity factor as well. When an object isn't conspicuous, it is easier to be inattentionally blind to it. People tend to notice items if they capture their attention in some way. If the object isn't visually prominent or relevant, there is a higher chance that a person will miss it.

Mental workload is a person's cognitive resources. The amount of a person's workload can interfere with processing of other stimuli. When a person focuses a lot of attention on one stimulus, he/she focuses less attention on other stimuli. For example, talking on the phone while driving the attention is mostly focused on the phone conversation, so there is less attention focused on driving. The mental workload could be anything from thinking about tasks that need to be done to tending to a baby in the backseat. When people have most of their attention focused on one thing, they are more vulnerable to inattentional blindness. However, the opposite is true as well. When a person has a very small mental workload he/she is doing an everyday task the task becomes automatic. Automatic processing can lessen one's mental workload, which can lead to a person to missing the unexpected stimuli.

Working memory also contributes to inattentional blindness. Cognitive psychologists have examined the relationship between working memory and inattention, but evidence is inconclusive. The rate of this phenomenon can be impacted by a number of factors. Researchers have found evidence for a number of components that may play a role. These include features of the object and the current task, where an individual's attention lies relative to the object, and mental workload as mentioned above. Researchers Kreitz, Furley, and Memmery in 2015, asserted that working memory capacity is not an indicator of susceptibility to inattentional blindness. Instead, it is a combination of what stimulus the attention is directed to as well as the individual's personal expectations. There are individual differences that can play a role, but some argue those disparities are separate from capacity for working memory.[49] On the other hand, there are researchers who consider differences between individuals and their working memory capacity to be a stronger determinant of inattentional blindness. Seegmiller, Watson, and Strayer in 2011 for example, studied individual differences in working memory capacity and how that overall impacted their attention on a given task. They utilized the same Invisible Gorilla video Simons and Chabris did (as mentioned above), but they additionally had participants complete a mathematics test to measure their capacity. From their results, they were able to find a high correlation between an individual's working memory capacity and their susceptibility to inattentional blindness. Those who were calculated to have a lower capacity, more often experienced the blindness.[50]

In a follow up study the same year, Kreitz and her team looked specifically at the cognitive abilities between individuals. Her team employed a variety of tasks, both static and dynamic, to compare the participants who had their cognitive capacity measured beforehand. Even though they included different tasks to test individuals, there was not a measurable relationship between the cognitive abilities of a participant and their attention performance. They did, however, find evidence to support the idea that noticing a certain stimuli was better in those demonstrating expertise in the task subject (referenced above). Overall, Kreitz concluded that cognitive/working memory capacity might not be an accurate measure for inattentional blindness. Instead, they determined that the rate of noticing might be both circumstantial and dependent on the requirements of the task.[51]

There are also researchers who subscribe to the idea that working memory does not play a measurable role in attentional blindness. This is different from the study by Kreitz and her team finding that individual differences in cognitive abilities might not be relative to noticing rates. Bredemeier and Simons conducted two studies in 2012. The first involved identifying the location of letters as well as counting how many times a group of shapes touched one another. These served as spatial and attention tasks respectively. The second study utilized the same tasks as the previous, but included a verbal one. Participants had to solve math problems and then remember a particular letter that followed each equation. From their results, the two researchers questioned if there was a relationship between noticing a particular stimuli and cognitive abilities. Instead of other factors contributing to the working memory of an individual's noticing, Bredemeier and Simons postulated that external variables establish the appearance of this relationship. Finally, the two researchers attempted to explain why studies were yielding conflicting results. The reason for why this research seems particularly inconclusive might be a result of disparities between the design of the actual research. Essentially, a variety of confounded variables might be prevalent across the studies when considering methodology and sampling processes. A more regulated, large-scale experiment could lead to more conclusive findings.[52]

When a person expects certain things to happen, he/she tends to block out other possibilities. This can lead to inattentional blindness. For example, person X is looking for their friend at a concert, and that person knows their friend (person Y) was wearing a yellow jacket. In order to find person Y, person X looks around for people wearing yellow. It is easier to pick a color out of the crowd than a person. However, if person Y took off the jacket, there is a chance person X could walk right past person Y and not notice because he/she was looking for the yellow jacket. Because of expectations, experts are more prone to inattentional blindness than beginners. An expert knows what to expect when certain situations arise. Therefore, that expert will know what to look for. This could cause that person to miss out on other important details that he/she may not have been looking for.

Attentional capacity, or neurological salience, is a measure of how much attention must be focused to complete a task. For example, an expert pianist can play a piano without thinking much, but a beginner would have to consciously think of every note they hit. This capacity can be lessened by drugs, alcohol, fatigue, and age. With a small capacity, it is more possible to miss things. Therefore, if a person is drunk, he/she will probably miss more than a sober person would. If your attentional capacity is large, you are less likely to experience inattentional blindness.

William James addressed the benefits of attention by saying, "Only those items which I notice shape my mind without selective interest, experience is utter chaos".[53] Humans have a limited mental capacity that is incapable of attending to all the sights, sounds and other inputs that rush the senses every moment. Inattentional blindness is beneficial in the sense that it is a mechanism that has evolved with attention to help filter out irrelevant input, allowing only important information to reach consciousness.[53] Several researchers, notably James J. Gibson, have argued that, even before the retina, perception begins in the ecology, which has turned perceptual processes into informational relationships in the environment through evolution.[54] This allows humans to focus our limited mental resources more efficiently in our environment. For example, New et al. maintain that survival required monitoring animals, both human and non-human, to become part of the evolutionary adaptiveness of the human species. They found that when participants were shown an image with a rapidly altering scene where the scene change included an animate or inanimate object that the participants were significantly better at identifying humans and animals. New et al. argue that better performance in detecting animals and humans is not a factor of acquired expertise, rather it is an evolved survival mechanism in human perception.[54]

Inattentional blindness is also beneficial as a response to advertising overload.[55] Irrelevant marketing makes it more likely for consumers to ignore initiatives that aim at capturing their attention. This phenomenon called 'purposeful blindness' has a compelling illustration regarding banner ads. Banner blindness shows that consumers can adopt fast and become good at ignoring marketing messages that are not relevant.

Although the bulk of inattentional blindness research has been conducted in laboratory studies, the phenomenon occurs in a variety of everyday contexts. Depending upon the context, the occurrence of inattentional blindness could range from embarrassing and/or humorous to potentially devastating.

Several recent studies of explicit attention capture have found that when observers are focused on some other object or event, they often experience inattentional blindness.[26] This finding has potentially tragic implications for distracted driving. If a person's attention is focused elsewhere while driving, carrying on a conversation or text messaging, for example, they could fail to notice salient and distinctive objects, such as a stop sign, which could lead to serious injury and possibly even death. There have also been heinous incidents attributed to inattentional blindness behind the wheel. For example, a Pennsylvania highway crew accidentally paved over a dead deer that was lying on the road. When questioned regarding their actions, the workers claimed to have never seen it.[30]

Many policies are being implemented around the world to decrease the competition for explicit attention capture while operating a vehicle. For example, there are legislative efforts in many countries aimed at banning or restricting the use of cell phones while driving. Research has shown that the use of both hands-free and hand-held cellular devices while driving results in the failure of attention to explicitly capture other salient and distinctive objects, leading to significantly delayed reaction times, as well as inattentional blindness.[56] A study published in 1997, based on accident data in Toronto, found the risk involved in driving while using a cell phone to be similar to that of driving drunk. In both cases, the risk of a collision was three to six times higher compared to a sober driver not using a cell phone.[57] Moreover, Strayer et al. (2006) found that when controlling for driving difficulty and time on task, cell-phone drivers exhibited greater impairment than intoxicated drivers, using a high-fidelity driving simulator.[58]

Inattentional blindness is also prevalent in aviation. The development of heads-up display (HUD) for pilots, which projects information onto the windshield or onto a helmet-mounted display, has enabled pilots to keep their eyes on the windshield, but simulator studies have found that HUD may cause runway incursion accidents, where one plane collides with another on the runway.[53] This finding is particularly concerning because HUDs are being employed in automobiles, which could lead to potential roadway incursions.[53] When a particular object or event captures attention to the extent to which the beholders' attentional capacity is completely absorbed, the resulting inattentional blindness has been known to cause dramatic accidents. For example, an airliner crew, engrossed with a blinking console light, failed to notice the approaching ground and register hearing the danger alarm sounding before the airliner crashed.[53]

Collaborative efforts to establish links between science and illusion have examined the relationship of the processes underlying inattentional blindness and the concept of misdirectiona magician's ability to manipulate attention in order to prevent his/her audience from seeing how a trick was performed. In several misdirection studies, including Kuhn and Tatler (2005),[59] participants watch a "vanishing item" magic trick. After the initial trial, participants are shown the trick until they detect the item dropping from the magician's hand. Most participants see the item drop on the second trial. The critical analyses involved differences in eye movements between the detected and undetected trials. These repetition trials are similar to the full-attention trial in the inattentional blindness paradigm, as both involve the detection of the unexpected event and, by detecting the unexpected event on the second trial, demonstrate that the event is readily perceivable.[60]

The main difference between inattentional blindness and misdirection involves how attention is manipulated. While inattentional blindness tasks require an explicit distractor, the attentional distraction in misdirection occurs through the implicit yet systematic orchestration of attention.[60] Moreover, there are several varieties of misdirection and different types are likely to induce different cognitive and perceptual processes, which vary the misdirection paradigm's resemblance to inattentional blindness.[60]

Although the aims of magic and illusion differ from those of neuroscience, magicians wish to exploit cognitive weaknesses, whereas neuroscientists seek to understand the brain and the neuronal significance of cognitive functions. Several researchers have argued that neuroscientists and psychologists can learn from incorporating the real world experience and knowledge of magicians into their fields of research. The techniques developed over centuries of stage magic by magicians may also be utilized by neuroscience as powerful probes of human cognition.[61]

When a police officer's version of events differs from video or forensic evidence, inattentional blindness has been used by defense lawyers as a possibility.[62] The criticism of this defense is that this view could be used to defend nearly any police shooting.[63]

See original here:
Inattentional blindness - Wikipedia

Read More...

Conditions and Diseases Treated | Adult Stem Cell Therapy

January 14th, 2019 10:46 am

As pioneers in the field, TruStem Cell Therapy provides evidence-based care customized to suit patient needs in a safe, effective manner. The discovery of stem cells opened a whole new understanding of how healing works in the human body. TruStem Cell Therapy uses that science to provide access to therapy for painful and debilitating conditions.

Adult stem cells are natural healers that have almost limitless capabilities. Emerging evidence shows that adult stem cells are able to create completely unrelated cells making them valuable assets in the fight to treat many diseases.

TruStem Cell Therapy provides access to the stem cell therapy and the bodys own healing resources as a therapy for life-changing illnesses. Stem cells have the ability to develop into different cell types and aid in repairing the damage done by illness. This means they work with your body to heal tissue, help manage pain and relieve symptoms.

Our board certified surgeons have access to the latest research and state-of-the-art equipment, allowing them to harvest stem cells effectively and efficiently utilizing the least-invasive methods available. The goal is to provide access to patient-centric care with therapy using stem cells, giving the power back to patients. At TruStem Cell Therapy, we specialize in conditions treated with stem cells, such as:

Originally posted here:
Conditions and Diseases Treated | Adult Stem Cell Therapy

Read More...

Stem Cell Therapy: Alternative To Hip Replacement …

January 14th, 2019 10:46 am

The usage of hip replacement and surgery has grown dramatically over the years and has even become more common among younger people. However, surgery is not the only solution. At the Institute of Regenerative Medicine, we offer stem cell therapy for hip joints as a safe and effective alternative to hip replacement or surgery.

Stem cell therapy for hip joints is an outpatient procedure that takes a few hours to complete. The process begins with the abstraction of stem cells and platelet rich plasma, also referred to as PRP, from the patients blood and bone marrow.

Stem cells are the natural healing mechanism in the human body. They have the ability to morph into other types of cells that are needed to repair a damaged hip joint such as muscle, cartilage, or bone cells. This results in the stem cells restoring your hip joints naturally without the need of drugs or hip surgery. However, as we age, the number of stem cells in our body and their potency decline. This causes our body to heal slower or not at all from joint injuries in the hip. To counter this, we have developed a proprietary technique to revitalize the patients stem cells and inject a high concentration of them directly to the damaged area of the hip joint with the PRP

Once injected into the hip joint, the stem cells will being restoring the damaged areas of the hip. The PRP, which contains many growth factors, will act as a stimulate for the stem cells, helping to increase their healing potential. After the injection, patients can go home immediately.

Hip surgery often requires patients to stay in a hospital overnight for several days and is followed by several months of physical therapy or training. With a hip replacement, patients are advised to avoid certain movements such as bending and twisting for up to a 12 month period. And even after a patients hip joint has healed after surgery, patients may not be permitted to do certain high impact activities such as sports, jogging, and dancing.

This is not the case for patients that elect to have stem cell therapy for their hip joint injuries. In most cases, patients can resume their active lifestyles without any restrictions or the need of extensive physical therapy in a short amount of time. Typically, patients will begin to see a response from the stem cells in about three weeks after the injection. After that, patients will experience a significant reduction in pain while regaining full mobility of their hip joints in the next several weeks as the stem cells continue to restore the hip joint.

Our medical team will determine the exact treatment and the number of stem cell injections after examining your medical files. Typically, a single stem cell injection is all that is needed to repair most hip joint injuries. If the injury in the hip joint is more severe, then additional injections will be needed. In these cases, we inject additional PRP into the hip joint a month after the first injection to stimulate the initially injected stem cells to prolong their healing process, and then another injection a few weeks after that.

Stem cell therapy for hip joints is a safe alternative to hip replacement or surgery since stem cells and platelet rich plasma (PRP) are biological components that already exist in the human body. Because we harvest the stem cells and PRP for the patients blood instead of other sources, the virtually no risk of rejection or harm to the patients health. Furthermore, the procedure is done by a board certified orthopedic surgeon.

At the Institute of Regenerative Medicine, we have successfully treated patients with various hip injuries and conditions including:

If you suffer from any of these conditions or experience hip pain, contact our office to see if you are a candidate for stem cell therapy for hip joints.

To maximize success, we tailor our stem cell treatment based on the unique needs of our patients. For this reason, the cost for hip stem cell treatment will vary greatly from case to case and can only be determined after our orthopedic specialist has evaluated a patients hip joint. Factors that will determine the cost of stem cell treatment includes:

It is important to note that most health insurance companies will not cover the cost for hip stem cell treatment. However, in many cases, the cost of stem cell therapy can be similar to the cost patients will pay out of pocket for hip surgery and post-surgical care with insurance.

See more here:
Stem Cell Therapy: Alternative To Hip Replacement ...

Read More...

Neil Riordan PhD – Medistem Panama

January 13th, 2019 6:50 am

Neil Riordan, PhD is the founder and chairman of Medistem Panama, Inc., (MPI) a leading stem cell laboratory and research facility located in the Technology Park at the prestigious City of Knowledge in Panama City, Panama. Founded in 2007, MPI stands at the forefront of applied research on adult stem cells for several chronic diseases. MPIs stem cell laboratory is ISO 9001 certified and fully licensed by the Panamanian Ministry of Health. Dr. Riordan is the founder of Stem Cell Institute (SCI) in Panama City, Panama (est. 2007).

Under the umbrella of MPI subsidiary Translational Biosciences, MPI and SCI are currently conducting five IRB-approved clinical trials in Panama for multiple sclerosis, rheumatoid arthritis and osteoarthritis using human umbilical cord-derived mesenchymal stem cells, mesenchymal trophic factors and stromal vascular fraction. Additional trials for spinal cord injury, autism and cerebral palsy are slated to commence in 2014 upon IRB approval.

Dr. Riordans research team collaborates with a number of universities and institutions, including National Institutes of Health, Indiana University, University of California, San Diego, University of Utah, University of Western Ontario, and University of Nebraska.

Dr. Riordan has published over 60 scientific articles in international peer-reviewed journals and authored two book chapters on the use of non-controversial stem cells from placenta and umbilical cord. In the stem cell arena, he and his colleagues have published more than 20 articles on Multiple Sclerosis, Spinal Cord Injury, Heart Failure, Rheumatoid Arthritis, Duchenne Muscular Dystrophy, Autism, and Charcot Marie Tooth Syndrome. In 2007, Dr. Riordans research team was the first to discover and document the existence of mesenchymal-like stem cells in menstrual blood. For this discovery, his team was honored with the Medical Article of the Year Award from Biomed Central. Other notable journals in which Dr. Riordan has published articles include the British Journal of Cancer, Cellular Immunology, Journal of Immunotherapy, and Translational Medicine.

Dr. Riordan is an accomplished inventor; listed on more the 25 patent families, including 11 issued patents. He is credited with a number of novel discoveries in the field of cancer research since the mid-1990s when he collaborated with his father Dr. Hugh Riordan on the effects of high-dose intravenous vitamin C on cancer cells and the tumor microenvironment. This pioneering study on vitamin Cs preferential toxicity to cancer cells notably led to a 1997 patent grant for the treatment of cancer with vitamin C. In 2010, Dr. Riordan received another patent for a new cellular cancer vaccine.

Dr. Riordan is also the founder of Aidan Products, which provides health care professionals with quality nutraceuticals including Stem-Kine, the only nutritional supplement that is clinically proven to increase the amount of circulating stem cells in the body for an extended period of time. Stem-Kine is currently sold in 35 countries.

Dr. Riordan earned his Bachelor of Science at Wichita State University and graduated magna cum laude. He received his Masters degree at the University of Nebraska Medical Center. Dr. Riordan completed his education by earning a Ph.D. in Health Sciences at Medical University of the America

Continued here:
Neil Riordan PhD - Medistem Panama

Read More...

Arthritis Pain Relief Products | TYLENOL

January 13th, 2019 6:49 am

Arthritis Pain Relief Products | TYLENOLSkip to main content

Asset Name:

1.2_Arthritis_Products_Marquee.jpg

Dont let Arthritis get in the way of your day. TYLENOL 8 HR ARTHRITIS Pain provides two layers of pain relief that work fast and last all day*

*Up to 8 hours

Works fast and lasts all day, up to 8 hours.Available as caplets.

Log in using your account with

By registering, you agree to receive additional communications regarding product information, promotions, newsletters and surveys from our site. If you choose to register with a social provider, certain information will be shared by your social provider with our site.

{* traditionalSignIn_signInButton *}

Welcome back, {* welcomeName *}!

Welcome back!

{* traditionalSignIn_signInButton *}

All Fields required, unless otherwise indicated

Will be used as your user name

By submitting your information above, you agree that the information you provide will be governed by our site's Privacy Policy.

By submitting your information you agree to our sites Privacy Policy.

All fields required unless otherwise indicated

Will be used as your user name

Your first name and last initial will be displayed publicly to other users when you write a review or blog post (ex. John S.).

Who in your household do you buy TYLENOL for? Select all that apply:{* answerWhoBuyMyself *}{* answerWhoBuyAnotherAdult *}{* answerWhoBuyChildren *}

If you have children, what ages are they? Select all that apply:{* answerChildrenNone *}{* answerChildrenUpToOne *}{* answerChildrenUpToFive *}{* answerChildrenUpToEleven *}{* answerChildrenUpToEighteen *}

Which of the following describes your household's use of products from TYLENOL ? Select all that apply:{* answerProductMinorAches *}{* answerProductMinorArthritis *}{* answerProductPostSurgical *}{* answerProductHeadache *}{* answerProductPremenstrual *}{* answerProductPain *}{* answerProductFever *}{* answerProductCold *}

By submitting your information above, you agree that the information you provide will be governed by our site's Privacy Policy.

All fields required

Looks like you have an existing account with us. We have made some changes to our site and we need you to create a new password in order to login. Click send to recieve an email with instructions on how to create your new password.

Please check your email for a reset link to continue the reset process.

{* mergeAccounts *}

By clicking "Accept" below, you confirm that you have read, understand and accept our sites's Privacy Policy

You do not meet the minimum age requirement to sign in to this site

The rest is here:
Arthritis Pain Relief Products | TYLENOL

Read More...

7 Foods Arthritis Sufferers Should Avoid – HealthPrep

January 13th, 2019 6:49 am

Arthritis is a condition that stems from the degeneration and/or overuse of joints, mostly affecting the knees, fingers, and hips. Australia (15%) and the United States (over 20%) have some of the highest rates of arthritis in the Western world. Evidence of arthritis has even been discovered in dinosaurs as well as being found in human remains from as early as 4500 BC. Today, people with arthritis can manage joint pain and swelling in a variety of ways, including what they consume in their everyday diet. Although there is no prescriptive diet for arthritis sufferers, this article will explore 7 foods that people with arthritis should stay away from. As always, consult your physician before making major changes in your diet.

It has long been known that fried food is bad for just about anyone due to the amount of saturated fat. A lot of fried food is also from a freezer and is often overly processed, as well as being high in salt and artificial preservatives. These all have a negative effect on a person with arthritis. Consuming a lot of fried food also has a connection to obesity, which in turn can fast track the degenerative process of joints; this is due to the extra weight and load being placed on the knees and hips. Fried meats should specifically be avoided by arthritis sufferers.

Read the original:
7 Foods Arthritis Sufferers Should Avoid - HealthPrep

Read More...

Stem Cell Regenerative Medicine Conferences 2018 Zurich …

January 11th, 2019 11:45 pm

Sessions/Tracks

Conference Series LLC LTD invites all the participants from all over the world to attend 10th Annual Conference onStem Cell and Regenerative Medicineduring October 08-09, 2018 atZurich, Switzerland which includes prompt keynote presentations, oral talks, poster presentations, networking, and exhibitions.

Track : Stem Cell

An undifferentiated cell of a multicellular creature which is fit for offering to ascend to inconclusively more cells of the same sort, and from which certain different sorts of cell emerge by separation. The most entrenched and generally utilized undifferentiated organism treatment is the transplantation of blood foundational microorganisms to treat infections and states of the blood and invulnerable framework or to restore the blood framework after medications for particular growths. Subsequent to the 1970s, skin undifferentiated organisms have been utilized to develop skin joins for patients with serious smolders on expansive territories of the body. Just a couple of clinical focuses can do this treatment and it is normally held for patients with life-debilitating blazes. It is likewise not a flawless arrangement: the new skin has no hair follicles or sweat organs. Research went into enhancing the strategy is continuous.

Related societies:

Europe: European Consortium for Stem Cell Research ; Cambridge Stem Cell Initiative ; Swiss Stem Cell Network ; The Scottish Stem Cell Network ; Danish Stem Cell Society ; European Society of Gene and Cell Therapy ; French Stem Cell Research Society ; Polish Society for Regenerative Medicine ; Spanish Society for Gene and Cell Therapy ; Irish Stem Cell Foundation ; Austrian Society for Stem Cell Research ; Austrian Society of Regenerative Medicine ; German Stem Cell Network.

USA: New York Stem Cell Foundation ; U.S. Stem Cell, Inc ; Stem Cell Clinical Trials ; International Society for Stem Cell Research ; Society for Hematology and Stem Cells ; Stem Cell Action Network ; Student Society for Stem Cell Research ; Tissue Engineering and Regenerative Medicine International Society ; International Society for Stem Cells Applications ; The Transplantation Society ; The American Society of Gene & Cell Therapy.

Asia Pacific and Middle East: Stem Cell Society Singapore ; Taiwan Society for Stem Cell Research ; The New South Wales Stem Cell Network ; Australian Society for Stem Cell Research ; Society for Tissue Engineering and Regenerative Medicine, India ; Korean Tissue Engineering and Regenerative Medicine Society ; Japanese Society for Regenerative Medicine ; Taiwan Association of ProloTherapy and Regenerative Medicine ; Stem Cell Society of India.

Track : Stem Cell Niche

A stem-cell niche is an area of a tissue that provides a specific microenvironment, in which stem cells are present in an undifferentiated and self-renewable state. Cells of the stem-cell niche interact with the stem cells to maintain them or promote their differentiation. The general niche model involves the association between resident stem cells and heterologous cell typesthe niche cells.

RelatedStem Cell Conferences|Stem Cell Congress|Regenerative Medicine Conferences| Stem Cell Meetings

CSHL Germ Cells Conference, USA, October 9-13, 2018 ; Conference on Regenerative Biology and Applications, Hong Kong, October 15-19, 2018 ; New York Stem Cell Foundation Conference, USA, October 23-24, 2018 ; Symposium on Translation of Stem Cells to the Clinic, Challenges and Opportunities, USA, December 02-04, 2018 ; From Stem Cells to Human Development Conference, UK, September 23-26, 2018 ; 6th Cambridge International Stem Cell Symposium, UK, September 19-21, 2018 ; Modeling Cell-Cell Interactions Governing Tissue Repair & Disease, USA, August 19-24, 2018 ; Stem Cells in Disease Modelling and Drug Discovery, Australia, June 17-18, 2018 ; ISSCR 2018 Annual Meeting, Australia, June 20-23, 2018 ; Precision CRISPR Stem Cell Congress, USA, June 12-14, 2018 ; Conference on Hematopoietic Stem Cells: From the Embryo to the Aging Organism, Germany, June 07-09, 2018 ; Conference on Manufacturing and Testing of Pluripotent Stem Cells, USA, June 5-6, 2018 ; Cell & Gene Meeting, USA, October 3-5, 2018. Trends and Challenges in Regenerative Medicine and Cell Therapy, Germany, March 2529, 2018 ; The Stem Cell Niche Conference, Denmark, May 27-31, 2018.

Related societies:

Europe: Belgian Society for Stem Cell Research ; UK Stem Cell Foundation ; International Stem Cell Forum ; British Society for Gene and Cell Therapy ; UK Regenerative Medicine Platform ; Austrian Society of Regenerative Medicine ; Scan Balt Stem Cell Research Network ; Student Society for Stem Cell Research ; Norwegian Center for Stem Cell Research ; Lund Stem Cell Center ; Stem Cell Network North Rhine-Westphalia ; UK Stem Cell Bank ; European Group for Blood and Marrow Transplantation ; Israel Stem Cell Society.

USA: Maryland Stem Cell Research Commission ; Harvard College Stem Cell Society ; International Society for Cellular Therapy ; California Institute for Regenerative Medicine ; American Society of Transplantation ; American Society for Matrix Biology ; American Society for Cell Biology ; National Stem Cell Foundation ; Perinatal Stem Cell Society ; International Placenta Stem Cell Society ; American Society for Blood and Marrow Transplantation ; Columbia University Stem Cell Initiative ; The American Regenerative Medicine Society.

Asia Pacific and Middle East: Hong Kong Stem Cell Society ; Chinese Society for Cell Biology ; Korean Society for Stem Cell Research ; Pakistan Stem Cell Society ; StemCell Thai Red Cross ; Iranian Stem Cell Council ; The Japanese Society for Regenerative Medicine ; Formosa Association Regenerative Medicine ; Iranian Societyfor HematopoieticStem CellTransplantation ; International Society of Regenerative Medicine ; Japan Human Cell Society (Stem Cell).

Track :Induced Pluripotent Stem Cells

iPSC is derived from skin or blood cells that have been reprogrammed back into an embryonic-like pluripotent state that enables the development of an unlimited source of any type of human cell needed for therapeutic purposes. The discovery of induced pluripotent stem cells (iPSCs) has opened up unprecedented opportunities in the pharmaceutical industry, in the clinic, and in laboratories. In particular, the medical applications of human iPSCs in disease modeling and stem cell therapy have been progressing rapidly. The ability to induce cell fate conversion is attractive not only for these applications but also for basic research fields, such as development, cancer, epigenetics, and aging.

RelatedStem Cell Conferences|Stem Cell Congress|Regenerative Medicine Conferences|ConferenceSeries Ltd

CSHL Germ Cells Conference, USA, October 9-13, 2018 ; Conference on Regenerative Biology and Applications, Hong Kong, October 15-19, 2018 ; New York Stem Cell Foundation Conference, USA, October 23-24, 2018 ; Symposium on Translation of Stem Cells to the Clinic, Challenges and Opportunities, USA, December 02-04, 2018 ; From Stem Cells to Human Development Conference, UK, September 23-26, 2018 ; 6th Cambridge International Stem Cell Symposium, UK, September 19-21, 2018 ; Modeling Cell-Cell Interactions Governing Tissue Repair & Disease, USA, August 19-24, 2018 ; Stem Cells in Disease Modelling and Drug Discovery, Australia, June 17-18, 2018 ; ISSCR 2018 Annual Meeting, Australia, June 20-23, 2018 ; Precision CRISPR Stem Cell Congress, USA, June 12-14, 2018 ; Conference on Hematopoietic Stem Cells: From the Embryo to the Aging Organism, Germany, June 07-09, 2018 ; Conference on Manufacturing and Testing of Pluripotent Stem Cells, USA, June 5-6, 2018 ; Cell & Gene Meeting, USA, October 3-5, 2018. Trends and Challenges in Regenerative Medicine and Cell Therapy, Germany, March 2529, 2018 ; The Stem Cell Niche Conference, Denmark, May 27-31, 2018.

Related societies:

Europe: European Consortium for Stem Cell Research ; Cambridge Stem Cell Initiative ; Swiss Stem Cell Network ; The Scottish Stem Cell Network ; Danish Stem Cell Society ; European Society of Gene and Cell Therapy ; French Stem Cell Research Society ; Polish Society for Regenerative Medicine ; Spanish Society for Gene and Cell Therapy ; Irish Stem Cell Foundation ; Austrian Society for Stem Cell Research ; Austrian Society of Regenerative Medicine ; German Stem Cell Network.

USA: New York Stem Cell Foundation ; U.S. Stem Cell, Inc ; Stem Cell Clinical Trials ; International Society for Stem Cell Research ; Society for Hematology and Stem Cells ; Stem Cell Action Network ; Student Society for Stem Cell Research ; Tissue Engineering and Regenerative Medicine International Society ; International Society for Stem Cells Applications ; The Transplantation Society ; The American Society of Gene & Cell Therapy.

Asia Pacific and Middle East: Stem Cell Society Singapore ; Taiwan Society for Stem Cell Research ; The New South Wales Stem Cell Network ; Australian Society for Stem Cell Research ; Society for Tissue Engineering and Regenerative Medicine, India ; Korean Tissue Engineering and Regenerative Medicine Society ; Japanese Society for Regenerative Medicine ; Taiwan Association of ProloTherapy and Regenerative Medicine ; Stem Cell Society of India.

Track : Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells traditionally found in the bone marrow. However, mesenchymal stem cells can also be isolated from other tissues including cord blood, peripheral blood, fallopian tube, and fetal liver and lung. Multipotent stem cells, MSCs differentiate to form adipocytes, cartilage, bone, tendons, muscle, and skin. Mesenchymal stem cells are a distinct entity to the mesenchyme, embryonic connective tissue which is derived from the mesoderm and differentiates to form hematopoietic stem cells.

RelatedStem Cell Conferences|Stem Cell Congress|Regenerative Medicine Conferences|Stem Cell Meetings

CSHL Germ Cells Conference, USA, October 9-13, 2018 ; Conference on Regenerative Biology and Applications, Hong Kong, October 15-19, 2018 ; New York Stem Cell Foundation Conference, USA, October 23-24, 2018 ; Symposium on Translation of Stem Cells to the Clinic, Challenges and Opportunities, USA, December 02-04, 2018 ; From Stem Cells to Human Development Conference, UK, September 23-26, 2018 ; 6th Cambridge International Stem Cell Symposium, UK, September 19-21, 2018 ; Modeling Cell-Cell Interactions Governing Tissue Repair & Disease, USA, August 19-24, 2018 ; Stem Cells in Disease Modelling and Drug Discovery, Australia, June 17-18, 2018 ; ISSCR 2018 Annual Meeting, Australia, June 20-23, 2018 ; Precision CRISPR Stem Cell Congress, USA, June 12-14, 2018 ; Conference on Hematopoietic Stem Cells: From the Embryo to the Aging Organism, Germany, June 07-09, 2018 ; Conference on Manufacturing and Testing of Pluripotent Stem Cells, USA, June 5-6, 2018 ; Cell & Gene Meeting, USA, October 3-5, 2018. Trends and Challenges in Regenerative Medicine and Cell Therapy, Germany, March 2529, 2018 ; The Stem Cell Niche Conference, Denmark, May 27-31, 2018.

Related societies:

Europe: Belgian Society for Stem Cell Research ; UK Stem Cell Foundation ; International Stem Cell Forum ; British Society for Gene and Cell Therapy ; UK Regenerative Medicine Platform ; Austrian Society of Regenerative Medicine ; Scan Balt Stem Cell Research Network ; Student Society for Stem Cell Research ; Norwegian Center for Stem Cell Research ; Lund Stem Cell Center ; Stem Cell Network North Rhine-Westphalia ; UK Stem Cell Bank ; European Group for Blood and Marrow Transplantation ; Israel Stem Cell Society.

USA: Maryland Stem Cell Research Commission ; Harvard College Stem Cell Society ; International Society for Cellular Therapy ; California Institute for Regenerative Medicine ; American Society of Transplantation ; American Society for Matrix Biology ; American Society for Cell Biology ; National Stem Cell Foundation ; Perinatal Stem Cell Society ; International Placenta Stem Cell Society ; American Society for Blood and Marrow Transplantation ; Columbia University Stem Cell Initiative ; The American Regenerative Medicine Society.

Asia Pacific and Middle East: Hong Kong Stem Cell Society ; Chinese Society for Cell Biology ; Korean Society for Stem Cell Research ; Pakistan Stem Cell Society ; StemCell Thai Red Cross ; Iranian Stem Cell Council ; The Japanese Society for Regenerative Medicine ; Formosa Association Regenerative Medicine ; Iranian Societyfor HematopoieticStem CellTransplantation ; International Society of Regenerative Medicine ; Japan Human Cell Society (Stem Cell).

Track : Cancer Stem Cells

Cancer stem cells (CSCs) are cancer cells (found in tumors or hematological cancers) that possess characteristics associated with normal stem cells. CSCs may generate tumors through the stem cell processes of self-renewal and differentiation into multiple cell types. Such cells are hypothesized to persist in tumors as a distinct population and cause relapse and metastasis by giving rise to new tumors. Therefore, development of specific therapies targeted at CSCs holds hope for improvement of survival and quality of life of cancer patients, especially for patients with metastatic disease.

RelatedStem Cell Conferences|Stem Cell Congress|Regenerative Medicine Conferences|Stem Cell Meetings

CSHL Germ Cells Conference, USA, October 9-13, 2018 ; Conference on Regenerative Biology and Applications, Hong Kong, October 15-19, 2018 ; New York Stem Cell Foundation Conference, USA, October 23-24, 2018 ; Symposium on Translation of Stem Cells to the Clinic, Challenges and Opportunities, USA, December 02-04, 2018 ; From Stem Cells to Human Development Conference, UK, September 23-26, 2018 ; 6th Cambridge International Stem Cell Symposium, UK, September 19-21, 2018 ; Modeling Cell-Cell Interactions Governing Tissue Repair & Disease, USA, August 19-24, 2018 ; Stem Cells in Disease Modelling and Drug Discovery, Australia, June 17-18, 2018 ; ISSCR 2018 Annual Meeting, Australia, June 20-23, 2018 ; Precision CRISPR Stem Cell Congress, USA, June 12-14, 2018 ; Conference on Hematopoietic Stem Cells: From the Embryo to the Aging Organism, Germany, June 07-09, 2018 ; Conference on Manufacturing and Testing of Pluripotent Stem Cells, USA, June 5-6, 2018 ; Cell & Gene Meeting, USA, October 3-5, 2018. Trends and Challenges in Regenerative Medicine and Cell Therapy, Germany, March 2529, 2018 ; The Stem Cell Niche Conference, Denmark, May 27-31, 2018.

Related societies:

Europe: European Consortium for Stem Cell Research ; Cambridge Stem Cell Initiative ; Swiss Stem Cell Network ; The Scottish Stem Cell Network ; Danish Stem Cell Society ; European Society of Gene and Cell Therapy ; French Stem Cell Research Society ; Polish Society for Regenerative Medicine ; Spanish Society for Gene and Cell Therapy ; Irish Stem Cell Foundation ; Austrian Society for Stem Cell Research ; Austrian Society of Regenerative Medicine ; German Stem Cell Network.

USA: New York Stem Cell Foundation ; U.S. Stem Cell, Inc ; Stem Cell Clinical Trials ; International Society for Stem Cell Research ; Society for Hematology and Stem Cells ; Stem Cell Action Network ; Student Society for Stem Cell Research ; Tissue Engineering and Regenerative Medicine International Society ; International Society for Stem Cells Applications ; The Transplantation Society ; The American Society of Gene & Cell Therapy.

Asia Pacific and Middle East: Stem Cell Society Singapore ; Taiwan Society for Stem Cell Research ; The New South Wales Stem Cell Network ; Australian Society for Stem Cell Research ; Society for Tissue Engineering and Regenerative Medicine, India ; Korean Tissue Engineering and Regenerative Medicine Society ; Japanese Society for Regenerative Medicine ; Taiwan Association of ProloTherapy and Regenerative Medicine ; Stem Cell Society of India.

Track :Hematopoietic Stem Cells

Hematopoietic stem cells (HSCs) are multipotent, self-renewing progenitor cells that develop from mesodermal hemangioblast cells. All differentiated blood cells from the lymphoid and myeloid lineages arise from HSCs. HSCs can be found in the adult bone marrow, peripheral blood, and umbilical cord blood. More recent advances have resulted in the use of HSC transplants in the treatment of cancers and other immune system disorders.

RelatedStem Cell Conferences|Stem Cell Congress|Regenerative Medicine Conferences|Stem Cell Meetings

CSHL Germ Cells Conference, USA, October 9-13, 2018 ; Conference on Regenerative Biology and Applications, Hong Kong, October 15-19, 2018 ; New York Stem Cell Foundation Conference, USA, October 23-24, 2018 ; Symposium on Translation of Stem Cells to the Clinic, Challenges and Opportunities, USA, December 02-04, 2018 ; From Stem Cells to Human Development Conference, UK, September 23-26, 2018 ; 6th Cambridge International Stem Cell Symposium, UK, September 19-21, 2018 ; Modeling Cell-Cell Interactions Governing Tissue Repair & Disease, USA, August 19-24, 2018 ; Stem Cells in Disease Modelling and Drug Discovery, Australia, June 17-18, 2018 ; ISSCR 2018 Annual Meeting, Australia, June 20-23, 2018 ; Precision CRISPR Stem Cell Congress, USA, June 12-14, 2018 ; Conference on Hematopoietic Stem Cells: From the Embryo to the Aging Organism, Germany, June 07-09, 2018 ; Conference on Manufacturing and Testing of Pluripotent Stem Cells, USA, June 5-6, 2018 ; Cell & Gene Meeting, USA, October 3-5, 2018. Trends and Challenges in Regenerative Medicine and Cell Therapy, Germany, March 2529, 2018 ; The Stem Cell Niche Conference, Denmark, May 27-31, 2018.

Related societies:

Europe: European Consortium for Stem Cell Research ; Cambridge Stem Cell Initiative ; Swiss Stem Cell Network ; The Scottish Stem Cell Network ; Danish Stem Cell Society ; European Society of Gene and Cell Therapy ; French Stem Cell Research Society ; Polish Society for Regenerative Medicine ; Spanish Society for Gene and Cell Therapy ; Irish Stem Cell Foundation ; Austrian Society for Stem Cell Research ; Austrian Society of Regenerative Medicine ; German Stem Cell Network.

USA: New York Stem Cell Foundation ; U.S. Stem Cell, Inc ; Stem Cell Clinical Trials ; International Society for Stem Cell Research ; Society for Hematology and Stem Cells ; Stem Cell Action Network ; Student Society for Stem Cell Research ; Tissue Engineering and Regenerative Medicine International Society ; International Society for Stem Cells Applications ; The Transplantation Society ; The American Society of Gene & Cell Therapy.

Asia Pacific and Middle East: Stem Cell Society Singapore ; Taiwan Society for Stem Cell Research ; The New South Wales Stem Cell Network ; Australian Society for Stem Cell Research ; Society for Tissue Engineering and Regenerative Medicine, India ; Korean Tissue Engineering and Regenerative Medicine Society ; Japanese Society for Regenerative Medicine ; Taiwan Association of ProloTherapy and Regenerative Medicine ; Stem Cell Society of India.

Track :Embryonic Stem Cells

Embryonic Stem Cells are immortal cells having an almost unlimited developmental potential. These are made from cells found in very early human embryos, called blastocysts. Many scientists are working how to create specialized cell types found in the body by exposing Embryonic Stem Cells to different conditions which they can use to treat numerous different diseases, like multiple sclerosis, blindness, and diabetes.

RelatedStem Cell Conferences|Stem Cell Congress|Regenerative Medicine Conferences|Stem Cell Meetings

CSHL Germ Cells Conference, USA, October 9-13, 2018 ; Conference on Regenerative Biology and Applications, Hong Kong, October 15-19, 2018 ; New York Stem Cell Foundation Conference, USA, October 23-24, 2018 ; Symposium on Translation of Stem Cells to the Clinic, Challenges and Opportunities, USA, December 02-04, 2018 ; From Stem Cells to Human Development Conference, UK, September 23-26, 2018 ; 6th Cambridge International Stem Cell Symposium, UK, September 19-21, 2018 ; Modeling Cell-Cell Interactions Governing Tissue Repair & Disease, USA, August 19-24, 2018 ; Stem Cells in Disease Modelling and Drug Discovery, Australia, June 17-18, 2018 ; ISSCR 2018 Annual Meeting, Australia, June 20-23, 2018 ; Precision CRISPR Stem Cell Congress, USA, June 12-14, 2018 ; Conference on Hematopoietic Stem Cells: From the Embryo to the Aging Organism, Germany, June 07-09, 2018 ; Conference on Manufacturing and Testing of Pluripotent Stem Cells, USA, June 5-6, 2018 ; Cell & Gene Meeting, USA, October 3-5, 2018. Trends and Challenges in Regenerative Medicine and Cell Therapy, Germany, March 2529, 2018 ; The Stem Cell Niche Conference, Denmark, May 27-31, 2018.

Related societies:

Europe: Belgian Society for Stem Cell Research ; UK Stem Cell Foundation ; International Stem Cell Forum ; British Society for Gene and Cell Therapy ; UK Regenerative Medicine Platform ; Austrian Society of Regenerative Medicine ; Scan Balt Stem Cell Research Network ; Student Society for Stem Cell Research ; Norwegian Center for Stem Cell Research ; Lund Stem Cell Center ; Stem Cell Network North Rhine-Westphalia ; UK Stem Cell Bank ; European Group for Blood and Marrow Transplantation ; Israel Stem Cell Society.

USA: Maryland Stem Cell Research Commission ; Harvard College Stem Cell Society ; International Society for Cellular Therapy ; California Institute for Regenerative Medicine ; American Society of Transplantation ; American Society for Matrix Biology ; American Society for Cell Biology ; National Stem Cell Foundation ; Perinatal Stem Cell Society ; International Placenta Stem Cell Society ; American Society for Blood and Marrow Transplantation ; Columbia University Stem Cell Initiative ; The American Regenerative Medicine Society.

Asia Pacific and Middle East: Hong Kong Stem Cell Society ; Chinese Society for Cell Biology ; Korean Society for Stem Cell Research ; Pakistan Stem Cell Society ; StemCell Thai Red Cross ; Iranian Stem Cell Council ; The Japanese Society for Regenerative Medicine ; Formosa Association Regenerative Medicine ; Iranian Societyfor HematopoieticStem CellTransplantation ; International Society of Regenerative Medicine ; Japan Human Cell Society (Stem Cell).

Track :Adult Stem Cells

Track :Stem Cell Therapy

Stem cell therapyis used to treat or prevent diseases by using stem cells. It has potential in a wide range of territories of potential and restorative examination. This treatment is by and large used to supplant or repair harmed cells or tissues. It additionally helps intransplanting immature microorganismsor giving medications those objective undifferentiated organisms as of now in the body. Undeveloped cell treatment is a rising innovation; the recovery of the body part is not really another idea.

RelatedStem Cell Conferences|Stem Cell Congress|Regenerative Medicine Conferences|Stem Cell Meetings

CSHL Germ Cells Conference, USA, October 9-13, 2018 ; Conference on Regenerative Biology and Applications, Hong Kong, October 15-19, 2018 ; New York Stem Cell Foundation Conference, USA, October 23-24, 2018 ; Symposium on Translation of Stem Cells to the Clinic, Challenges and Opportunities, USA, December 02-04, 2018 ; From Stem Cells to Human Development Conference, UK, September 23-26, 2018 ; 6th Cambridge International Stem Cell Symposium, UK, September 19-21, 2018 ; Modeling Cell-Cell Interactions Governing Tissue Repair & Disease, USA, August 19-24, 2018 ; Stem Cells in Disease Modelling and Drug Discovery, Australia, June 17-18, 2018 ; ISSCR 2018 Annual Meeting, Australia, June 20-23, 2018 ; Precision CRISPR Stem Cell Congress, USA, June 12-14, 2018 ; Conference on Hematopoietic Stem Cells: From the Embryo to the Aging Organism, Germany, June 07-09, 2018 ; Conference on Manufacturing and Testing of Pluripotent Stem Cells, USA, June 5-6, 2018 ; Cell & Gene Meeting, USA, October 3-5, 2018. Trends and Challenges in Regenerative Medicine and Cell Therapy, Germany, March 2529, 2018 ; The Stem Cell Niche Conference, Denmark, May 27-31, 2018.

Related societies:

Europe: Belgian Society for Stem Cell Research ; UK Stem Cell Foundation ; International Stem Cell Forum ; British Society for Gene and Cell Therapy ; UK Regenerative Medicine Platform ; Austrian Society of Regenerative Medicine ; Scan Balt Stem Cell Research Network ; Student Society for Stem Cell Research ; Norwegian Center for Stem Cell Research ; Lund Stem Cell Center ; Stem Cell Network North Rhine-Westphalia ; UK Stem Cell Bank ; European Group for Blood and Marrow Transplantation ; Israel Stem Cell Society.

USA: Maryland Stem Cell Research Commission ; Harvard College Stem Cell Society ; International Society for Cellular Therapy ; California Institute for Regenerative Medicine ; American Society of Transplantation ; American Society for Matrix Biology ; American Society for Cell Biology ; National Stem Cell Foundation ; Perinatal Stem Cell Society ; International Placenta Stem Cell Society ; American Society for Blood and Marrow Transplantation ; Columbia University Stem Cell Initiative ; The American Regenerative Medicine Society.

Asia Pacific and Middle East: Hong Kong Stem Cell Society ; Chinese Society for Cell Biology ; Korean Society for Stem Cell Research ; Pakistan Stem Cell Society ; StemCell Thai Red Cross ; Iranian Stem Cell Council ; The Japanese Society for Regenerative Medicine ; Formosa Association Regenerative Medicine ; Iranian Societyfor HematopoieticStem CellTransplantation ; International Society of Regenerative Medicine ; Japan Human Cell Society (Stem Cell).

Track :Stem Cell Transplantation

Stem cell transplantation, also referred to as bone marrow transplant, in which unhealthy blood-forming cells replace with healthy cells. Stem cell transplantation in combination with doses of chemotherapy or radiation therapy increases the chance of eliminating blood cancer in the marrow. Many researchers are working to improve stem cell transplantation procedures to make it an option for patients.arrangement: the new skin has no hair follicles or sweat organs. Research went into enhancing the method is progressing.

RelatedStem Cell Conferences|Stem Cell Congress|Regenerative Medicine Conferences|Stem Cell Meetings

CSHL Germ Cells Conference, USA, October 9-13, 2018 ; Conference on Regenerative Biology and Applications, Hong Kong, October 15-19, 2018 ; New York Stem Cell Foundation Conference, USA, October 23-24, 2018 ; Symposium on Translation of Stem Cells to the Clinic, Challenges and Opportunities, USA, December 02-04, 2018 ; From Stem Cells to Human Development Conference, UK, September 23-26, 2018 ; 6th Cambridge International Stem Cell Symposium, UK, September 19-21, 2018 ; Modeling Cell-Cell Interactions Governing Tissue Repair & Disease, USA, August 19-24, 2018 ; Stem Cells in Disease Modelling and Drug Discovery, Australia, June 17-18, 2018 ; ISSCR 2018 Annual Meeting, Australia, June 20-23, 2018 ; Precision CRISPR Stem Cell Congress, USA, June 12-14, 2018 ; Conference on Hematopoietic Stem Cells: From the Embryo to the Aging Organism, Germany, June 07-09, 2018 ; Conference on Manufacturing and Testing of Pluripotent Stem Cells, USA, June 5-6, 2018 ; Cell & Gene Meeting, USA, October 3-5, 2018. Trends and Challenges in Regenerative Medicine and Cell Therapy, Germany, March 2529, 2018 ; The Stem Cell Niche Conference, Denmark, May 27-31, 2018.

Related societies:

Europe: European Consortium for Stem Cell Research ; Cambridge Stem Cell Initiative ; Swiss Stem Cell Network ; The Scottish Stem Cell Network ; Danish Stem Cell Society ; European Society of Gene and Cell Therapy ; French Stem Cell Research Society ; Polish Society for Regenerative Medicine ; Spanish Society for Gene and Cell Therapy ; Irish Stem Cell Foundation ; Austrian Society for Stem Cell Research ; Austrian Society of Regenerative Medicine ; German Stem Cell Network.

USA: New York Stem Cell Foundation ; U.S. Stem Cell, Inc ; Stem Cell Clinical Trials ; International Society for Stem Cell Research ; Society for Hematology and Stem Cells ; Stem Cell Action Network ; Student Society for Stem Cell Research ; Tissue Engineering and Regenerative Medicine International Society ; International Society for Stem Cells Applications ; The Transplantation Society ; The American Society of Gene & Cell Therapy.

Asia Pacific and Middle East: Stem Cell Society Singapore ; Taiwan Society for Stem Cell Research ; The New South Wales Stem Cell Network ; Australian Society for Stem Cell Research ; Society for Tissue Engineering and Regenerative Medicine, India ; Korean Tissue Engineering and Regenerative Medicine Society ; Japanese Society for Regenerative Medicine ; Taiwan Association of ProloTherapy and Regenerative Medicine ; Stem Cell Society of India.

Track :Somatic Cell Therapy

Somatic cell treatment is the organization to people of autologous, allogeneic, or xenogeneic living cells which have been controlled or prepared ex vivo. Assembling of items for substantial cell treatment includes the ex vivo proliferation, development, choice. Substantial cell treatment is seen as a more moderate, more secure methodology since it influences just the focused on cells in the patient, and is not went on to future eras. Substantial quality treatment speaks to standard essential and clinical exploration, in which helpful DNA (either incorporated in the genome or as an outside episome or plasmid) is utilized to treat illness. Most concentrate on the extreme hereditary issue, including immunodeficiencies, hemophilia, thalassemia and cystic fibrosis. Such single quality issue is the great possibility for substantial cell treatment.

RelatedStem Cell Conferences|Stem Cell Congress|Regenerative Medicine Conferences|Stem Cell Meetings

CSHL Germ Cells Conference, USA, October 9-13, 2018 ; Conference on Regenerative Biology and Applications, Hong Kong, October 15-19, 2018 ; New York Stem Cell Foundation Conference, USA, October 23-24, 2018 ; Symposium on Translation of Stem Cells to the Clinic, Challenges and Opportunities, USA, December 02-04, 2018 ; From Stem Cells to Human Development Conference, UK, September 23-26, 2018 ; 6th Cambridge International Stem Cell Symposium, UK, September 19-21, 2018 ; Modeling Cell-Cell Interactions Governing Tissue Repair & Disease, USA, August 19-24, 2018 ; Stem Cells in Disease Modelling and Drug Discovery, Australia, June 17-18, 2018 ; ISSCR 2018 Annual Meeting, Australia, June 20-23, 2018 ; Precision CRISPR Stem Cell Congress, USA, June 12-14, 2018 ; Conference on Hematopoietic Stem Cells: From the Embryo to the Aging Organism, Germany, June 07-09, 2018 ; Conference on Manufacturing and Testing of Pluripotent Stem Cells, USA, June 5-6, 2018 ; Cell & Gene Meeting, USA, October 3-5, 2018. Trends and Challenges in Regenerative Medicine and Cell Therapy, Germany, March 2529, 2018 ; The Stem Cell Niche Conference, Denmark, May 27-31, 2018.

Related societies:

Europe: European Consortium for Stem Cell Research ; Cambridge Stem Cell Initiative ; Swiss Stem Cell Network ; The Scottish Stem Cell Network ; Danish Stem Cell Society ; European Society of Gene and Cell Therapy ; French Stem Cell Research Society ; Polish Society for Regenerative Medicine ; Spanish Society for Gene and Cell Therapy ; Irish Stem Cell Foundation ; Austrian Society for Stem Cell Research ; Austrian Society of Regenerative Medicine ; German Stem Cell Network.

USA: New York Stem Cell Foundation ; U.S. Stem Cell, Inc ; Stem Cell Clinical Trials ; International Society for Stem Cell Research ; Society for Hematology and Stem Cells ; Stem Cell Action Network ; Student Society for Stem Cell Research ; Tissue Engineering and Regenerative Medicine International Society ; International Society for Stem Cells Applications ; The Transplantation Society ; The American Society of Gene & Cell Therapy.

Asia Pacific and Middle East: Stem Cell Society Singapore ; Taiwan Society for Stem Cell Research ; The New South Wales Stem Cell Network ; Australian Society for Stem Cell Research ; Society for Tissue Engineering and Regenerative Medicine, India ; Korean Tissue Engineering and Regenerative Medicine Society ; Japanese Society for Regenerative Medicine ; Taiwan Association of ProloTherapy and Regenerative Medicine ; Stem Cell Society of India.

Track :Regenerative Medicine

Organ and tissue loss through disease and injury motivate the development of therapies that can regenerate tissues and decrease reliance on transplantations. Regenerative medicine, an interdisciplinary field that applies engineering and life science principles to promote regeneration, can potentially restore diseased and injured tissues and whole organs.

RelatedStem Cell Conferences|Stem Cell Congress|Regenerative Medicine Conferences|Stem Cell Meetings

CSHL Germ Cells Conference, USA, October 9-13, 2018 ; Conference on Regenerative Biology and Applications, Hong Kong, October 15-19, 2018 ; New York Stem Cell Foundation Conference, USA, October 23-24, 2018 ; Symposium on Translation of Stem Cells to the Clinic, Challenges and Opportunities, USA, December 02-04, 2018 ; From Stem Cells to Human Development Conference, UK, September 23-26, 2018 ; 6th Cambridge International Stem Cell Symposium, UK, September 19-21, 2018 ; Modeling Cell-Cell Interactions Governing Tissue Repair & Disease, USA, August 19-24, 2018 ; Stem Cells in Disease Modelling and Drug Discovery, Australia, June 17-18, 2018 ; ISSCR 2018 Annual Meeting, Australia, June 20-23, 2018 ; Precision CRISPR Stem Cell Congress, USA, June 12-14, 2018 ; Conference on Hematopoietic Stem Cells: From the Embryo to the Aging Organism, Germany, June 07-09, 2018 ; Conference on Manufacturing and Testing of Pluripotent Stem Cells, USA, June 5-6, 2018 ; Cell & Gene Meeting, USA, October 3-5, 2018. Trends and Challenges in Regenerative Medicine and Cell Therapy, Germany, March 2529, 2018 ; The Stem Cell Niche Conference, Denmark, May 27-31, 2018.

Related societies:

Europe: Belgian Society for Stem Cell Research ; UK Stem Cell Foundation ; International Stem Cell Forum ; British Society for Gene and Cell Therapy ; UK Regenerative Medicine Platform ; Austrian Society of Regenerative Medicine ; Scan Balt Stem Cell Research Network ; Student Society for Stem Cell Research ; Norwegian Center for Stem Cell Research ; Lund Stem Cell Center ; Stem Cell Network North Rhine-Westphalia ; UK Stem Cell Bank ; European Group for Blood and Marrow Transplantation ; Israel Stem Cell Society.

USA: Maryland Stem Cell Research Commission ; Harvard College Stem Cell Society ; International Society for Cellular Therapy ; California Institute for Regenerative Medicine ; American Society of Transplantation ; American Society for Matrix Biology ; American Society for Cell Biology ; National Stem Cell Foundation ; Perinatal Stem Cell Society ; International Placenta Stem Cell Society ; American Society for Blood and Marrow Transplantation ; Columbia University Stem Cell Initiative ; The American Regenerative Medicine Society.

Asia Pacific and Middle East: Hong Kong Stem Cell Society ; Chinese Society for Cell Biology ; Korean Society for Stem Cell Research ; Pakistan Stem Cell Society ; StemCell Thai Red Cross ; Iranian Stem Cell Council ; The Japanese Society for Regenerative Medicine ; Formosa Association Regenerative Medicine ; Iranian Societyfor HematopoieticStem CellTransplantation ; International Society of Regenerative Medicine ; Japan Human Cell Society (Stem Cell).

Track :Tissue Regeneration

Tissue Engineering is the investigation of the development of new connective tissues, or organs, from cells and a collagenous platform to create a completely useful organ for implantation over into the contributor host. Effective improvements in the multidisciplinary field of tissue building have created a novel arrangement of tissue new parts and execution approaches. Investigative advances in biomaterials, foundational microorganisms, development and separation components, and biomimetic situations have made special chances to manufacture tissues in the research facility from blends of designed extracellular networks cells and organically dynamic particles.

RelatedStem Cell Conferences|Stem Cell Congress|Regenerative Medicine Conferences|Stem Cell Meetings

CSHL Germ Cells Conference, USA, October 9-13, 2018 ; Conference on Regenerative Biology and Applications, Hong Kong, October 15-19, 2018 ; New York Stem Cell Foundation Conference, USA, October 23-24, 2018 ; Symposium on Translation of Stem Cells to the Clinic, Challenges and Opportunities, USA, December 02-04, 2018 ; From Stem Cells to Human Development Conference, UK, September 23-26, 2018 ; 6th Cambridge International Stem Cell Symposium, UK, September 19-21, 2018 ; Modeling Cell-Cell Interactions Governing Tissue Repair & Disease, USA, August 19-24, 2018 ; Stem Cells in Disease Modelling and Drug Discovery, Australia, June 17-18, 2018 ; ISSCR 2018 Annual Meeting, Australia, June 20-23, 2018 ; Precision CRISPR Stem Cell Congress, USA, June 12-14, 2018 ; Conference on Hematopoietic Stem Cells: From the Embryo to the Aging Organism, Germany, June 07-09, 2018 ; Conference on Manufacturing and Testing of Pluripotent Stem Cells, USA, June 5-6, 2018 ; Cell & Gene Meeting, USA, October 3-5, 2018. Trends and Challenges in Regenerative Medicine and Cell Therapy, Germany, March 2529, 2018 ; The Stem Cell Niche Conference, Denmark, May 27-31, 2018.

Related societies:

Europe: European Consortium for Stem Cell Research ; Cambridge Stem Cell Initiative ; Swiss Stem Cell Network ; The Scottish Stem Cell Network ; Danish Stem Cell Society ; European Society of Gene and Cell Therapy ; French Stem Cell Research Society ; Polish Society for Regenerative Medicine ; Spanish Society for Gene and Cell Therapy ; Irish Stem Cell Foundation ; Austrian Society for Stem Cell Research ; Austrian Society of Regenerative Medicine ; German Stem Cell Network.

USA: New York Stem Cell Foundation ; U.S. Stem Cell, Inc ; Stem Cell Clinical Trials ; International Society for Stem Cell Research ; Society for Hematology and Stem Cells ; Stem Cell Action Network ; Student Society for Stem Cell Research ; Tissue Engineering and Regenerative Medicine International Society ; International Society for Stem Cells Applications ; The Transplantation Society ; The American Society of Gene & Cell Therapy.

Asia Pacific and Middle East: Stem Cell Society Singapore ; Taiwan Society for Stem Cell Research ; The New South Wales Stem Cell Network ; Australian Society for Stem Cell Research ; Society for Tissue Engineering and Regenerative Medicine, India ; Korean Tissue Engineering and Regenerative Medicine Society ; Japanese Society for Regenerative Medicine ; Taiwan Association of ProloTherapy and Regenerative Medicine ; Stem Cell Society of India.

Track : Regeneration and Therapeutics

See original here:
Stem Cell Regenerative Medicine Conferences 2018 Zurich ...

Read More...

RegenMD: Regenerative Medicine: Silver Spring, MD

January 11th, 2019 11:45 pm

About RegenMD

The staff at RegenMD in Silver Spring, Maryland is made up of board-certified physicians, orthopedic surgeons, physician assistants and physical therapists are ready to help you harness your bodys healing potential and regenerative capabilities. With the latest cutting-edge treatments to stimulate your bodys ability to repair itself, the RegenMD providers use a multidisciplinary approach and create a customized treatment plan to address your individual health needs.

The RegenMD providers offer a full spectrum of care that includes physical therapy, nonsurgical biologic regenerative treatments, and surgical intervention when necessary. The goal of treatment is to regenerate and restore the health of your musculoskeletal system to its optimal performance.

Their services including innovative treatments like stem cell therapy, platelet-rich plasma (PRP) treatments, prolotherapy, dry needling, and microneedling. Besides a full array of regenerative medical services, the team at RegenMD also offers courtesy concierge medical services if you are visiting the clinic from out of town.

The experienced and knowledgeable staff at RegenMD can alleviate your pain, improve your functionality, and get you back onto the field or into a healthier, physically active lifestyle.

New Location - Opening November 2018

7811 Montrose Road, 3rd floor, Potomac, Maryland 20854

See the article here:
RegenMD: Regenerative Medicine: Silver Spring, MD

Read More...

RMI | National Institutes of Health (NIH)

January 11th, 2019 11:45 pm

Background

Regenerative medicine is an emerging area of science that holds great promise for treating and even curing a variety of injuries and diseases. Regenerative medicine includes using stem cells and other technologiessuch as engineered biomaterials and gene editingto repair or replace damaged cells, tissues, or organs. Stem cell-based approaches are under development in labs around the world, and some have already moved into clinical trials. Such progress notwithstanding, much work remains to be done toward the development of safe and effective regenerative medicine products and to realize the full potential of this field.

The 21st Century Cures Act, passed in December 2016, established the Regenerative Medicine Innovation Project (RMIP) to accelerate the field by supporting clinical research on adult stem cells while promoting the highest standards for carrying out scientific research and protecting patient safety. In recognition of the integral role of the Food and Drug Administration (FDA) in the successful development of this field, NIH is leading the RMIP in coordination with FDA.

The 21st Century Cures Act authorizes $30 million in federal awards over four years (20172020) for the RMIP. Importantly, the Act requires award recipients to match the federal funds provided with at least an equal amount of non-federal funds.This matching requirement will amplify the federal investment and could help stimulate collaboration and develop key partnerships across the public and private sectors.

Congress allocated $2 million for the RMIP in FY 2017. To make optimal use of these funds, researchers were invited to submit applications for competitive revisions to support clinical studies involving adult stem cells. Eight awards were issued in September 2017.

On December 6-7, 2017, the NIH and FDA hosted a public Regenerative Medicine Innovation Workshop that brought together key stakeholders to explore the state of regenerative medicine clinical research involving adult stem cells with a focus on approaches to the development of safe and effective products. Video recordings from each session are available. The deliberations at this workshop were instrumental in helping to identify some of the major needs, opportunities, and challenges in the regenerative medicine field.

Input from the workshop and other sources informed the development of the next round of funding opportunity announcements (FOAs) published in August 2018. These FOAs solicit new investigator-initiated projects, which may either involve a clinical trial or entail late stage Investigational New Drug (IND)- or Investigational Device Exemption (IDE)-enabling clinical research. Applicants who have questions about these opportunities may consult our Frequently Asked Questions, and those with additional questions are encouraged to either consult the relevant program officer listed in the FOA, or write to RMIP@nih.gov.

Continued here:
RMI | National Institutes of Health (NIH)

Read More...

Regenerative Medicine | Olympia Orthopedics

January 11th, 2019 11:45 pm

What is Regenerative Medicine?

Regenerative Medicine is an exciting and innovative treatment option for orthopaedic conditions and sports injuries. These treatments utilize the bodys own naturally occurring healing mechanisms to help treat injuries and relieve pain. The two newest treatment options we offer for orthopaedic and sports injuries are Mesenchymal Stem Cell injections (Bone Marrow Aspirate Concentrate, BMAC) and Platelet Rich Plasma (PRP) injections. Collectively, these treatments are referred to as Regenerative Medicine.

The specialists at Olympia Orthopaedic Associates strive to provide patients with the best treatment options based on their individual conditions and lifestyles. Patients who are interested in discussing if they are candidates for these treatments should schedule an appointment with our Regenerative Medicine Specialists, Dr.Dominic Femiano and Dr. Tracy Hamblin.

Mesenchymal stem cells are the bodies own specialized cells that have the potential to develop into cells that can repair damaged tissue, ligaments or tendons. Essentially, these cells are the blank cells of the body that may adapt into the type of cells they are surrounded by. Each of us is born with these cells and we continue to produce them as we age.

Bone Marrow Aspirate Concentrate or BMAC stem cell treatment involves harvesting the bone marrow from the back of the pelvis and extracting the stem cells from that bone marrow. Once the BMAC stem cells have been isolated, they are then reinjected into the injured area.

When injected into an injured ligament, tendon or joint, these have the capability to take theform of the cells around them.

For instance, BMAC stem cells injected into damaged tissue have the capability to take the form of healthy tissue cells around them. This increases the likelihood of repair as many injuries lack the ability to heal well on their own.

The Regenerative Medicine Specialists at Olympia Orthopaedic Associates use only the bodies own naturally occurring cells and do not use donor cells or those from embryos or other sources.

Platelets are the component of blood and responsible for healing injuries. These platelets contain specialized proteins and growth factors that trigger the bodys natural healing response.

PRP treatment involves drawing blood from the patient and separating platelets and growth factors from the rest of the blood using a centrifuge. This process allows our specialists to extract the isolated platelets and inject a concentrated amount of PRP into an injured area.

Once injected, the platelets can expedite the healing process for certain injuries. This is due to specific proteins and growth factors contained in the platelet-rich plasma that decreases inflammation and can help damaged tissue or tendons.

BMAC stem cells and PRP are commonly used to treat inflammation, osteoarthritis, ligament and tendon injuries. Common injuries that our Regenerative Medicine Specialists treat include:

Research and clinical data have shown that PRP and BMAC stem cell treatments are extremely safe. Only your bodies own blood platelets or stem cells are injected into the injured area and the chance of the body rejecting its own blood or cells is extremely minimal.

When utilized in the right patients, Regenerative Medicine has shown to be highly effective.

In one study, published in The American Journal of Sports Medicine, 78% of those with osteoarthritis of the knee that received PRP injections showed a reduction in pain and increased function in the knee after one year.

The key to the effectiveness of these treatments is making sure that this treatment is right for you. Although Regenerative Medicine treatments have shown great results, there are some injuries that cannot be treated with BMAC stem cells or PRP such as complete tears of tendons or ligaments.

Our Regenerative Medicine Specialists are Board Certified and have undergone advanced training in the use of BMAC stem cells and PRP. We pride ourselves on using only the most evidence-based and scientifically proven Regenerative Medicine treatments to ensure effectiveness and patient safety.If you are interested in Regenerative Medicine for your orthopaedic or sports injury, please contact us to schedule a consultation at one of our locations throughout Olympia.

Go here to read the rest:
Regenerative Medicine | Olympia Orthopedics

Read More...

Regenerative Medicine Jobs, Employment | Indeed.com

January 11th, 2019 11:44 pm

Filter results by: Sortby: relevance - date

more

Functional Endocrinology of Ohio

Independence, OH 44131

$45,000 - $70,000 a year

ADVANCED STEM CELL INSTITUTE

Encino, CA 91316

Amnesty Health Group / Regenerative Health 360

Knoxville, TN

$100,000 - $150,000 a year

Pinnacle Intergrative Health PS

Seattle, WA

$2,000 - $3,000 a month

BlueRock Therapeutics

Amari Health

Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for...

BlueRock Therapeutics

BlueRock Therapeutics

Newbridge Health & Wellness

BlueRock Therapeutics

Centeno Schultz Clinic

Broomfield, CO

$18 - $20 an hour

Vitality Stem Cell and Aesthetic clinics

Roseville, CA

$40,000 - $100,009 a year

Be the first to see new Regenerative Medicine jobs

Research Associate salaries in United States

$49,527 per year

Indeed Salary Estimate

Please note that all salary figures are approximations based upon third party submissions to Indeed. These figures are given to the Indeed users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Here is the original post:
Regenerative Medicine Jobs, Employment | Indeed.com

Read More...

Regenerative Medicine Market Size | Industry Trends Report …

January 11th, 2019 11:44 pm

Industry Insights

The global regenerative medicine market size was estimated at USD 1,792.1 million in 2016. In recent years, regenerative medicine has emerged with promising approaches to treat complicated degenerative disorders as well as to support & restore the function of tissues and cells in other therapies. Rising prevalence of neurodegenerative, orthopedic, oncology, and genetic diseases coupled with advances in gene therapy, tissue engineering, and nanotechnology to support regenerative therapies are expected to boost revenue growth.

The industry has been witnessed to have a very strong pipeline with YoY increase in the number of products gaining approval for clinical application as well as the number of products entering into investigational trials for potential analysis. Growth is restricted due to regulatory and ethical issues in associated fields such as stem cells (SC) and gene editing. However, introduction of changes in regulatory policies and rise in demand for effective therapies to treat complicated disorders is projected to reduce the impact of these barriers over the forecast period.

UK regenerative medicine market revenue by product type, 2014 - 2025 (USD Million)

In addition, high investments by government and private organizations that support R&D, further encourage industry progress. Initiatives by government organizations to support stem cell & regenerative medicine R&D by providing funds and infrastructure facilities along with initiating various programs is expected to influence growth.

For instance, National Institutes of Health (NIH) supports scientific research community through NIH Regenerative Medicine Program, International SC Research, State Initiatives for Stem Cell Research, NIH SC Unit, NIH SC Libraries & Projects, and NIH SC Translation Laboratory.

Active participation by key companies is witnessed through strategic collaborations with academic institutes, government organizations, and major pharmaceutical & biotechnology companies. These initiatives are projected to make significant contributions in market expansion.

Considerable number of therapies in clinical trials are a collaborative effort of the market entities. Furthermore, key players are engaged in partnerships with universities to support development and gain commercial rights over innovative therapies.

Emerging technological advances in cell-based and gene therapies are attributed to be the major contributors to the industry progress. Introduction of flexible regulatory environment to conduct cell therapy research is expected to make lucrative contribution in market growth. IPSCs have witnessed rapid adoption in stem cell R&D to develop solutions for unmet clinical needs to treat complicated disorders.

On the contrary, regulatory restrictions to use HESC along with stringent regulatory norms that govern their application limits the market growth. However, identifying the potential clinical applications in countries such as U.S., UK, China, and Japan have introduced changes in their regulatory policies to encourage research. Thus, the industry is projected to reflect accelerated growth over the forecast period.

Gene therapy is projected to witness increased adoption in research owing to advances in gene sequencing and editing technology. Introduction of CRISPR and Cas gene technology that would to accelerate speed and enhance efficacy of gene-related research are expected to encourage use of gene therapy in treatment of genetic, metabolic, and degenerative disorders. Limited growth in gene therapy and Genetically Modified (GM) cell therapy is attributive to stringent regulatory restrictions pertaining the use of this technology.

Furthermore, advances in tissue engineering technology such as 3D printing of cells and tissues on scaffolds for transplant to restoring structural and functional characteristics of damaged cells, tissues, and organs is expected to make lucrative contributions towards market growth.

Dermatology is estimated to have largest share in revenue generation. This high contribution is attributive to presence of easy grafting techniques for dermatological wounds and diseases. Skin, being an organ with great cell replication characteristics, provides various types of stem cells from its different layers. Presence of broad range of product portfolio from patches to cure small injuries to matrix and grafts for chronic wounds and burns is expected to continue to dominate market through to the forecast period.

Owning to rise in demand for functional and structural restoration therapies along with rising incidences of bone & joint disorders, musculoskeletal segment is estimated to witness fastest growth. Rising prevalence of osteoarthritis with increase in geriatric population is anticipated to accelerate the segment growth.

Global regenerative market revenue by therapeutic category, 2016 (%)

Oncology is observed to be most promising segment owing to presence of strong pipeline of products and high investments in oncology research to treat as well as support treatment of various types of cancer, especially in incidences of cancer relapse. High incidence along with rising expenditure in treatment of oncology diseases have accelerated the developmental efforts in this segment. However, challenges in clinical trials are also high for this therapeutic category.

North America is estimated with highest share in revenue owing to presence of major players and rapid advances in technology along with high investments in stem cell & oncology research. Rapid uptake of advanced technology by the population is another significant factor contributing to the largest share.

Furthermore, active presences of organizations such as Alliance for Regenerative Medicine, National Institutes of Health, National Cancer Institute, International Society for Stem Cell Research, and National Stem Cell Foundation that promote R&D of regenerative medicine is expected to further accelerate growth in this region. Thereby, the region is projected to continue dominating the market through introduction of novel products.

Asia Pacific is projected to witness fastest growth over forecast period owing to high investments in healthcare research by the emerging economies in the region. Advances in stem cell research and presence of flexible regulatory environment for clinical adoption of cell-based regenerative therapies, China and Japan are expected to reflect rapid industrial progress.

In addition, availability of well-developed infrastructure and research facilities along with investments by government and private companies to support development of novel approaches is expected to further boost revenue growth. For instance, approvals to carry out research on human embryonic stem cells in China has encouraged researchers to explore the clinical potential of these cells. Thus, Asia Pacific is attributed to fastest growth over the forecast period.

The global regenerative medicine market is observed to be highly competitive and fragmented. The major players include Integra LifeSciences Corporation,MiMedx Group, Inc, AstraZeneca, F. Hoffmann-La Roche Ltd, Merck & Co., Inc., Pfizer Inc., Baxter and Nuvasive, Inc. These entities are observed to have high investments in development of regenerative therapies to capture the untapped potential by innovating novel therapies to meet the demand for unmet clinical needs.

In addition, key players are witnessed to focus on oncology & age-related degenerative disorders to compete in the market. Collaborative efforts & strategic agreements for technology sharing and product development have also been observed. Thereby, the industry witnesses a strong pipeline of products in clinical trials, which eventually are expected to drive revenue generation.

Attribute

Details

Base year for estimation

2016

Actual estimates/Historical data

2014 - 2016

Forecast period

2017 - 2025

Market representation

Revenue in USD Million and CAGR from 2017 to 2025

Regional scope

North America, Europe, Asia Pacific, Central & South America, Middle East & Africa

Country scope

U.S., Canada, Germany, UK, China, Japan, Brazil, South Africa

Report coverage

Revenue forecast, company share, competitive landscape, growth factors and trends

15% free customization scope (equivalent to 5 analyst working days)

If you need specific market information, which is not currently within the scope of the report, we will provide it to you as a part of customization

This report forecasts revenue growth at global, regional & country levels and provides an analysis on the industry trends in each of the sub-segments from 2014 to 2025. For the purpose of this study, Grand View Research has segmented the global regenerative medicine market on the basis of product, therapeutic categories, and region:

Product Type Outlook (Revenue, USD Million, 2014 - 2025)

Therapeutic Category Outlook (Revenue, USD Million, 2014 - 2025)

Regional Outlook (Revenue, USD Million, 2014 - 2025)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

Original post:
Regenerative Medicine Market Size | Industry Trends Report ...

Read More...

Regenerative Medicine | OAA

January 11th, 2019 11:44 pm

Regenerative Medicine Regenerative medicine therapies, including platelet-rich plasma and stem cell, help to heal injuries, both acute and chronic, by restoring the structure and function of damaged tissues. The conditions treated at OAA's Regenerative Medicine Institute include osteoarthritis, tendon injuries, and ligament and muscle tears. Using a patient's own tissue to initiate the healing process, regenerative medicine can help people restore function, help to delay or avoid surgery, and also be used as an adjunct to surgery.Platelet-Rich Plasma TherapyPlatelet-rich plasma (PRP) therapy is a regenerative medicine treatment option that uses components of the body's own blood cells to help relieve pain and accelerate healing.PRP is obtained from the patient through a simple blood draw and then put in a centrifuge that separates the platelet-rich part of the blood. The platelets are then injected back into the same patient's tendon, joint, or ligament. The platelet-rich plasma injection contains natural growth factors that aid in healing. This regenerative treatment option is becoming increasingly more popular among the sports medicine and orthopaedic communities as a non- operative procedure.

In some scenarios, your doctor might also recommend fat grafting in conjunction with your platelet-rich plasma therapy. Depending on your condition and site of injury, fat (adipose) cells are used as a matrix for the platelet-rich plasma to adhere to and help activate your healing cascade. Using a special device, adipose tissue (fat) is removed from an area of your body where it is stored easily, such as the abdomen. The adipose tissue is then injected into the affected area with the platelet-rich plasma to help enable the opportunity for natural healing and pain relief.

This non-surgical regenerative medicine treatment option involves extracting stem cells from bone marrow and injecting the stem cells into areas with damaged tissue. The body naturally uses its bone marrow stem cells to heal injuries and to help rebuild joints affected by degenerative joint disease. OAAs Regenerative Medicine Institute boosts the bodys healing process by harvesting stem cells from your pelvis and injecting them directly into the affected area. This procedure helps generate new healthy tissue and accelerates the healing process. This procedure is performed in our office in a sterile environment using local anesthesia and ultrasound guidance to ensure comfort and accuracy.

In some scenarios, your doctor might also recommend fat grafting and adipose derived stem cells in conjunction with your stem cell therapy. Depending on your condition and site of injury, fat cells are used as a matrix for bone marrow stem cells to adhere to and help activate your healing cascade. Using a special device, adipose tissue is removed from an area of your body where it is stored easily, such as the abdomen. The adipose tissue is then injected into the affected area with the bone marrow aspirate to help enable the opportunity for natural healing and pain relief.

Continue reading here:
Regenerative Medicine | OAA

Read More...

20 Best Regenerative Medicine jobs (Hiring Now!) | Simply Hired

January 11th, 2019 11:44 pm

University of Massachusetts Amherst - Amherst, MA4.4

Applicants with research and teaching expertise in areas of biomaterials for devices and regenerative medicine or biosensors and bioinstrumentation are...

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

This may consist of regenerative medicine therapies:. Synergy Medical is looking to hire a part-time physician to administer Fluoroscopy and Ultrasound guided...

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

We also offer regenerative medicine through Integrated Medicine of Ohio. Functional medicine training is preferred, but we will train the right candidate....

$45,000 - $70,000 a year3d

To serve as a practioner for a functional medicine clinic that reverses Type 2 Diabetes. We are looking for an MD....

$100,000 - $150,000 a year

Were looking for a highly motivated Controls Engineer to join our Regenerative Medicine Group. DEKA employs a team of over five hundred professionals, whose...

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for...

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

The RMC will provide evidence-based clinical care that utilizes a range of regenerative medicine therapies in conjunction with a coordinated research program...

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

A full-time Associate Researcher position is offered in the Department of Cell, Developmental and Regenerative Biology at the Icahn School of Medicine at Mount...

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

HJF is seeking a Clinical Research Assistant to support the Brody Lab within the Center for Neuroscience and Regenerative Medicine (CNRM) at Fort Belvoir...

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

HJF is seeking a Staff Scientist III to support and expanded Neuropathology/Neuroradiology Correlations/Integration Core Facility within the Center for...

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

Jackson Foundation (HJF) is seeking a Research Assistant to support the Center for Neuroscience and Regenerative Medicine (CNRM) in the Translational...

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

Regenerative Medicine Expansion. The Clinic is accepting applicants willing to learn Regenerative Medicine and High Definition Liposuction....

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

Scientist, Regenerative Medicine. The Astellas Institute of Regenerative Medicine (AIRM) is a wholly-owned subsidiary of Astellas Pharma and focused on the...

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

When you join us, you become a part of Mount Sinais unrivaled record of achievement, education and advancement as we revolutionize medicine together....

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

The Regenerative Medicine Technician will work under the direction of the laboratory CEO, medical director and operational manager....

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

Training will have a heavy emphasis on regenerative medicine procedures including stem cell therapies with adipose and bone marrow, platelet rich plasma (PRP),...

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

Scientific Writer - Wake Forest Institute for Regenerative Medicine, Full-time.Job Summary:. Facilitates the transfer of technologies emerging from basic...

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

BlueRock Therapeutics Cell+Gene regenerative medicine platform is based on state-of-the-art pluripotent stem cell engineering tools, and differentiation and...

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

Regenerative Biologics is a distribution company for biologic and regenerative medicine products. Our primary sales targets are in the Orthopedic and Sports...

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

BlueRock Therapeutics is an engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases....

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

Allergan is focused on developing, manufacturing and commercializing branded pharmaceutical, device, biologic, surgical and regenerative medicine products for...

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

The team so far is comprised of Niya Gupta (former McKinsey, Syngenta), Gabor and Andras Forgacs (Modern Meadow, Organovo) and Tony Atala (Wakeforest Institute...

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

Participation at global Regenerative Medicine conferences as required. Interest in the Regenerative Medicine application area, past hands-on experience or...

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

The practice also focuses on research with several ongoing clinical trials and cutting-edge therapies such as regenerative medicine procedures....

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

Regenerative Medicine experience appreciated. Current license to practice medicine as a Physician Assistant in California....

Please note that all salary figures are approximations based upon third party submissions to SimplyHired or its affiliates. These figures are given to the SimplyHired users for the purpose of generalized comparison only. Minimum wage may differ by jurisdiction and you should consult the employer for actual salary figures.

Send feedback or report inaccuracy

_Rrgenerative aesthetic medicine procedures and treatment approaches evaluating and developing a treatment plan for hormone optimization, stern cells in...

$40,000 - $100,000 a year

Go here to see the original:
20 Best Regenerative Medicine jobs (Hiring Now!) | Simply Hired

Read More...

Regenerative Medicine – Anatara Medicine

January 11th, 2019 11:44 pm

Ancient systems of medicine such as acupuncture and manipulative medicine have tapped into this capability to varying degrees by enhancing blood flow, nerve conduction and oxygenation to areas that need to be healed. As our understanding of the bodys own mechanisms for healing has matured, we have developed new techniques with a more robust healing potential.

In the field of Musculoskeletal Medicine, Prolotherapy, using a concentrated Dextrose (corn sugar) solution injected at the area requiring regeneration, can initiate the healing response. The first phase of healing is inflammation, where the blood flow to the area is increased bringing white blood cells to clean up the area and platelets with growth factors to stimulate stem cells to regenerate tissue.

The next evolution of Prolotherapy involved isolating the growth factors found in platelets and white blood cells in the blood and injecting them directly into the area to be healed. This is called Platelet Rich Plasma. Platelet Rich Plasma can be used to stimulate regeneration of muscles, tendons, ligaments, and cartilage, but it can also be used for a variety of aesthetic conditions like hair regrowth, facial rejuvenation, erectile dysfunction, stretch marks and scars.

For more information on the conditions we are currently treating and studying at the San Francisco Stem Cell Treatment Center, visit http://www.sfstemcellcenter.com.

All of these injections require that the needle be placed in the correct place so that the injured area is stimulated. This is why we use a state of the art, high-definition musculoskeletal ultrasound so we can see exactly where an injury is and ensure that solution is injected into that precise location. For instance, accuracy of the injection of the bursal sac, which can be inflamed in a variety of musculoskeletal conditions, was found to be improved from 14% to 97% using high-definition musculoskeletal ultrasound. There are some conditions where close is not good enough and musculoskeletal ultrasound is the only non-invasive, non-radioactive way of ensuring the correct placement of the medicine.

We tailor each package to meet your needs with the array of natural healthcare modalities we offer, and will work closely with you to help you realize your goals.

Please call 415.345.0099 or email info@anataramedicine.com to set up a complimentary 15-minute phone consultation so we may determine how our program may fit your specific needs. Our staff will be delighted to answer your questions.

See more here:
Regenerative Medicine - Anatara Medicine

Read More...

2017 Marks the 1st Year That Regenerative Medicine Disrupted …

January 11th, 2019 11:44 pm

The regenerative medicine industryhas been rapidly expanding over the past few years, making it a high-value, fast-growth market.Key drivers for the market include high rates of clinical trials,accelerated pathwaysfor product approvals, new technologies to supportcell and gene therapy manufacturing, and the potential for cell therapies to revolutionize healthcare.

The regenerative medicine market gained major momentum when the Swiss pharmaceutical giantNovartismade history as the first company to win FDA approval for a CAR-T cell therapy in the U.S. in August 2017 (Kymriah).In October 2017,Kite Pharmabecame the second company to get FDA approval of a CAR-T cell therapy (Yescarta).

With swelling momentum to support the CAR-T technology, there are now close to 40 companies developingredirected T cells or NK cellsfor therapeutic use.

On November 13, 2017, the FDA approved Abilify MyCite as the worldsfirst digital pill. With 7 out of 10 Americas taking at least one prescription drug, approval of the antipsychotic medication represents a breakthrough in digital medicine. Made by Japan-based Otsuka Pharmaceutical, the tablet works by containing a sensor to track when and if patients take their medication.

On December 19th, 2017, the FDA approved Spark TherapeuticsLuxturna,a novel gene therapy to treat patients with an inherited form of vision loss.

In addition to product approvals, there are now accelerated pathways for advanced therapy medicinal products (ATMPs) in several countries worldwide, including the U.S., Japan, and South Korea.Legislation took effect in Japan in late 2014, in South Korea in 2016, and in the United States in 2017.Additionally, the EU has a program for product acceleration the Adaptive Pathways. Although it is not explicitly for cell and gene therapies, it has been given a lot of attention by the group.

These historic events demonstrate to investors, the public, and funding providers alike that regenerative medicine is a sector that has emerged, no longer one that is evolving in the future.

Big Pharma is also demonstratingsnowballing interest in regenerative medicine.At its core, this is a strategic way for pharmaceutical companies to diversity their product development pipeline.In recent examples:

Finally, direct cell reprogramming is gaining momentum. Fortuna Fix, a company specializing in direct cell reprogramming applications to restore neuronal functionality, secured $25 million in Series B financing. The proceeds will enable the company to conduct Phase I/IIaclinical trials in Parkinsons Disease and Spinal Cord Injury.

Over the past 12-months, regenerative medicine has accelerated as a movement. With more than 600+ brave companies now composing the marketplace,immunotherapies, gene therapy, and digital medicinehave introduced true disruption of healthcare.

Today, the regenerative medicine industryincludes companies that are developing:

Interested to learn more about the industry? We spent exhaustivehours uncovering 600+ companies across the globe that are developing regenerative medicine therapeutics for use in humans.

2017 Marks the 1st Year That Regenerative Medicine Disrupted Healthcare

Read more:
2017 Marks the 1st Year That Regenerative Medicine Disrupted ...

Read More...

Human Genetics – medschool.ucla.edu

January 11th, 2019 11:40 pm

A hub of deep expertise, the Department of Human Genetics helps partners across UCLA interpret data and leverage genomic technology to improve study design and solve medical problems.

We demystify genetic complexities to provide vital insights for a range of clinical and research applications. We strive to improve the care of as many patients as possible by pushing our capabilities, developing novel ways to address unanswered questions.

Your next collaboration is right down the street.

Our enviable proximity to the worlds brightest scientific minds enables both thriving scheduled events and impromptu sidewalk powwows. A casual conversation during your coffee run could lead to your next big publication.

Come find out why innovation lives here.

LEARN MORE

Julian Martinez-Agosto, MD, PhDGenetic sequencing unravels rare disease mysteries; among the first medical centers to use exome sequencing.Learn More

Jingyi "Jessica" Li, PhDStatistics professor honored as a leading woman in STEM at the intersection of statistics and biology.Learn More

Aldons J. Lusis, PhDScientists identify 2 hormones that burn fat faster, prevent and reverse diabetes in mice.Learn More

Daniel Geschwind, MD, PhDAutism, schizophrenia, bipolar disorder share molecular traits, study finds.Learn More

Here is the original post:
Human Genetics - medschool.ucla.edu

Read More...

Stem cell therapy: FDA investigates clinics offering …

January 10th, 2019 2:50 pm

Inside Mark Bermans clinic in Rancho Mirage, California, is a sign hes obliged by law to post. It reads Not FDA Approved.

Patients who come here to the California Stem Cell Treatment Center can get treatments for ailments ranging from sports injuries to muscular dystrophy. For upward of $5,000, Berman, a plastic surgeon by training, will remove a small portion of their fat, process it, and inject it back into them.

This is called fat-derived stem cell therapy; the premise is that the stem cells in your fat can jump-start the healing process. The stem cells could be good for repairing everything from Alzheimers to paralysis to neurodegenerative conditions, says Berman. These cells are miraculous for helping heal. We dont have a choice. We have to use them.

The problem is theres not much evidence to back up the claims Berman is making. And its not just him there are more than 100 clinicians in the Cell Surgical Network, a group he co-founded in 2010 to promote the same kind of adult stem cell regenerative medicine he practices. According to a 2017 report by three Food and Drug Administration scientists in the New England Journal of Medicine looking at the benefits and risks of this kind of stem cell therapy, This lack of evidence is worrisome.

Fat-derived stem cells may have a positive effect, says Brad Olwin, a professor of molecular cellular and developmental biology at the University of Colorado Boulder with more than 30 years of experience working with stem cells. They may be beneficial; its clearly a possibility. The problem is the research hasnt been done.

So little evidence exists, in fact, that the Department of Justice, on behalf of the FDA, is suing Bermans clinic as well as a clinic in Florida for experimenting on patients with misleading products. The complaint was filed in May 2018 and the investigation is ongoing, according to the DOJ.

Given the popularity and abundance of these clinics nationwide, the FDA is also taking steps to modernize regulation in the field. But despite these efforts to streamline a path to legitimacy for stem cell clinics, unregulated medical procedures persist, at times leading to patient harm.

Currently, the only stem cell therapy approved by the FDA is a bone marrow transplant that uses pluripotent stem cells to treat cancers of the blood and bone marrow.

But doctors in the Cell Surgical Network have moved ahead with using cells for autoimmune, neurologic, and other serious conditions.

And there is a growing number of cases of adverse effects. In 2016, an elderly woman went blind after receiving an injection of stem cells to treat her macular degeneration. She received the treatment at the Stem Cell Center of Georgia an affiliate of Bermans Cell Surgical Network.

More reports of ill-fated procedures have since surfaced across the country, the worst resulting in kidney failure and paraplegia. In December, the Centers for Disease Control and Prevention reported 12 cases of people who suffered bacterial infections from contaminated stem cell treatments. An investigation traced the infections back to a single provider, Genetech, prompting the FDA to issue a warning letter to the company. FDA Commissioner Scott Gottlieb then issued a public statement reaffirming the agencys intent to regulate unapproved treatments.

Bioethicists are sounding the alarm too. In a recent paper in the journal Perspectives in Biology and Medicine, the University of Minnesotas Leigh Turner examined the marketing claims of 716 stem cell clinics in the United States. Often, he found, they were misleading. What at first glance might appear to be credible and compliant clinical research often is highly problematic, he wrote, adding that the individuals most affected are those who often are already dealing with serious health problems and other challenges.

Despite two years of increased scrutiny from the FDA, clinics continue to recruit new patients. Berman insists that repurposed fat-derived stem cells should not be subject to the same regulations as other treatments, and that FDA guidelines are arbitrary and nonscientific. They are a violation of constitutional rights to your own property.

He noted that after the case of the woman with macular degeneration going blind, his networks clinicians no longer inject fat-derived stem cells into patients eyes. But they continue to offer intravenous (bloodstream) injections. We have virtually three or four adverse events, of very little significance or consequence, says Berman, referring to the patients in his network. But according to the FDA, intravenous injections are associated with higher risk.

Other scientists I spoke with say theyre also worried that intravenous treatments may harm patients. Youre taking cells out of one part of your body, and putting them into another. You have absolutely no control after that, says Olwin. He acknowledges the FDAs efforts to crack down on clinics but suggests that much more can be done. They have limited resources to go after people. But I think its irresponsible for doctors and these clinics to be promoting these things.

Some types of stem cells can indeed give rise to virtually any cell in the body providing a platform for regenerating muscle or even rebuilding organs. Stem cells derived from embryos have this power, called pluripotency, but those obtained from adults do not. In order to acquire pluripotency, adult stem cells must be biologically reprogrammed a feat that, when invented, led to a Nobel Prize. These induced pluripotent stem cells allow doctors to treat challenging illnesses such as leukemia.

But clinics like Bermans are not using pluripotent stem cells they are using the mesenchymal stem cells found in fat, which are much more limited in function. Arnold Caplan, the fields pioneer who first gave them the stem cell label, recently advocated for renaming them to prevent doctors from claiming that they can cure the blind, make the lame walk, and make old tissue young again.

BrainStorm, a biotechnology company working with mesenchymal cells, recently gained FDA approval to begin clinical trials to treat patients suffering from multiple sclerosis. But to treat the neurological condition, BrainStorm researchers have developed a method to convert the mesenchymal cells into biological factories that release disease-treating proteins. In other words, BrainStorms therapy doesnt involve mesenchymal cells doing the work on their own what some clinics in the Cell Surgical Network claim mesenchymal cells can do.

Outside of the Cell Surgical Network, other clinics are using patients fat-derived cells but making different claims about the treatment.

I dont say Im doing stem cell therapy, says Dr. Joanne Halbrecht, an orthopedic surgeon and founder of Boulder Regenerative Medicine. Her clinic uses patients fat-derived cells to treat orthopedic conditions, injecting them into joints.

Halbrecht avoids the stem cell label because current research does not support claims that these fat-derived cells can turn into cartilage. Instead, she uses patients fat to cushion their joints. According to Olwin and the FDA, such joint injections are significantly lower-risk than intravenous injections.

Berman also administers direct joint injections. But afterward, he tells me, his clinicians also inject the leftover cells into the patients bloodstream. Halbrecht is adamant that this kind of procedure is unproven and unsafe.

Thats definitive. Its not a question, she says. They are completely wrong because there is zero science behind that.

For clinics to prove the safety and efficacy of their fat-derived stem cell treatments to the FDA, they must run rigorous clinical trials.

But some clinicians argue that even if they were interested in clinical trials, getting the FDAs blessing is too daunting. Clinical trials span years and cost millions of dollars. For small, privately owned clinics, this process is unaffordable.

In response, the FDA unveiled a more feasible clinical trial process, better suited to small businesses. Clinics that want to test a specific treatment can now team up on clinical trials and pool their patients, which can save them time and money. Still, the FDA is offering a grace period of up to 36 months for clinics to comply with its guidelines, allowing many to continue operating on patients without doing clinical trials. In the meantime, the FDA is urging patients to do [their] part to stay safe, according to a consumer warning issued in May.

Unfortunately, thats not so easy. Whether or not a clinic is offering an FDA-compliant treatment can be unclear. Some doctors advertise compliance because the device they use to remove and process a patients fat is technically FDA-approved. But if they then advertise their treatment as an FDA-approved stem cell therapy, they risk misleading patients.

Berman has no plans to pursue clinical trials, even with the new streamlined process. He believes his current model of clinical experimentation is adequate. In the so-called safety studies, he treats paying patients with a wide variety of diseases. But according to the recent bioethics report, Turner found that these pay-to-participate studies are poorly designed and unscientific.

In Bermans view, more patients benefit by obtaining cutting-edge treatments faster. But for every revolutionary treatment developed in a lab, there are nine duds and many unpredictable dangers. And unsanctioned clinics cost patients thousands of dollars and are not covered by insurance. Critics argue that it is unethical to charge patients for experimental procedures, as sanctioned clinical trials rarely cost patients anything.

The economic incentives for unsanctioned stem cell clinics are clear. Starting clinical trials would not only reduce patient revenue but also commit clinics to a costly process known to last for years. Shifting blame to the government and research community, Berman assures me that he and his colleagues are not motivated by self-interest. Were the good guys, he says.

In March, the woman blinded by an unsanctioned stem cell treatment filed a lawsuit against Bermans Cell Surgical Network. Bermans site still advertises treatment for macular degeneration with a link to an application.

But tucked away on Bermans website sits a sort of confession that may surprise the many patients who hear him speak with unwavering assurance. The page reads, We do not claim that these treatments work for any listed nor unlisted condition, intended or implied.

Max Levy is a PhD student in chemical and biological engineering at the University of Colorado Boulder and the senior editor of Science Buffs, a graduate student science blog. He writes about health, medicine, and the environment.

More:
Stem cell therapy: FDA investigates clinics offering ...

Read More...

Maintain Certification American Board of Preventive Medicine

January 9th, 2019 5:48 am

What is MOC?

MOC (Maintenance of Certification) is the board certification process for assessment of continuing competencies of physicians. The ABPM MOC program continues to evolve to meet American Board of Medical Specialties (ABMS) requirements.

Hold an active, valid and unrestricted medical license in all States, US territories, or Canadian Provinces in which you are licensed to practice medicine.

Complete continuing medical education and self-assessment activities in areas related to your practice. These include ABPM-approved courses as well as patient safety courses. View ABPM-approved LLSA courses.*

Pass a cognitive exam during each certification cycle. The exam will contain similar content to the initial certification exam. View MOC Exam Information.

Complete two Improvement in Medical Practice (IMP) activities. One of the activities must be completed through a Preventive Medicine specialty or subspecialty society (ACOEM, ACPM, AMIA, AsMA, UHMS).*

ABPM is a participant in the ABMS Multispecialty Portfolio Program. Activities completed through the program will be accepted. Learn more about the ABMS Multispecialty Portfolio Program.

*Diplomates completing MOC Parts 2 and 4 requirements for another ABMS Member Board may request reciprocal credit.

Read the original here:
Maintain Certification American Board of Preventive Medicine

Read More...

Holly Hansen, DVM – secaucusvet.com

January 9th, 2019 5:48 am

Dr. Holly Hansen is a born and raised Jersey girl. She completed her undergraduate studies at Felician College in Lodi, NJ graduating with a Bachelors degree in Biology. She earned her DVM degree in 2005 from Tufts University-School of Veterinary Medicine in North Grafton, MA. Soon after graduating from Tufts, she went on to further develop her veterinary skills by completing a one year small animal medicine and surgery internship at Arboretum View Animal Hospital right outside of Chicago.

Prior to becoming a veterinarian though, she worked at the Office of the Chief Medical Examiners Office in Newark, NJ covering multiple counties as a medical crime scene investigator for quite a few years.

Her interests in veterinary medicine include feline medicine, geriatric medicine, and internal medicine. She shares her home with a clowder of felines. She speaks cat, but absolutely loves all kinds of animals.

In her spare time, she enjoys the beach, going to the movies, concerts, music, anything Barry Manilow, and horror conventions.

See the rest here:
Holly Hansen, DVM - secaucusvet.com

Read More...

Page 908«..1020..907908909910..920930..»


2025 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick